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CHAPTER 1  
 
SYNTHESIS OF N-ACETYL AND C-TERT-BUTYL NATURAL AMINO ACID 
SUBSTRATES THAT MIMIC RESIDUES OF POLYPEPTIDES AND THEIR 
REACTIVITY WITH [FEIV(O)(N4PY)]2+: KINETIC AND MECHANISTIC 
INVESTIGATIONS 
 
1.1 Introduction 
Reactive oxygen species (ROS) such as singlet oxygen (1O2), superoxide (O2•–) 
and hydroxyl radical (OH•) can accumulate in the body’s oxygen rich environment,1, 2 
this process is known as oxidative stress and is well understood, especially using redox-
active metals and radiolysis for their generation.1-5 Oxidative stress can lead to 
physiological pathologies such as arteriosclerosis, ischemia/reperfusion injury, 
Alzheimer’s and neurodegenerative diseases as well as other age related diseases.6, 7  
The reactivity of proteins with metal-based oxidants, however, is an 
uninvestigated field. Metal-based oxidants, where the reactive oxygen is doubly bound to 
the metal center, represent another pathway to the oxidation of proteins. Metal-based 
oxidants offer an important advantage over ROS, such as the ability to tune their stability 
and selectivity with a substrate by alteration of either the metal center or the ligand 
structure.8 In tuning the stability and selectivity of the metal-based oxidant, the oxidation 
of proteins could be limited to a select few amino acid residues (where as ROS such as 
hydroxyl radical are non-discriminant). While metal-based oxidants have not been used 
to investigate protein oxidation, they are well known in nature.9-12  
Metal-based oxidants where the reactive metal center is iron are known as ferryls 
and are widely accepted as intermediates in heme and non-heme proteins that activate 
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dioxygen, such as cytochrome P450 and TauD, respectively.12, 13 Biomimetic non-heme 
ferryls have been shown to oxidize strong C-H bonds.8 The ferryl [FeIV(O)(N4Py)]2+  has 
been shown to be stable at room temperature for several days yet reacts to oxidize 
substrates upon addition. For example, [FeIV(O)(N4Py)]2+  affords cyclohexanol, via a 
hydroxylation, upon addition of cyclohexane.8 Due to this literature report and the fact 
that it has been well characterized, [FeIV(O)(N4Py)]2+ was chosen as the ferryl of interest 
for investigating the reactivity of metal-based oxidants with proteins. 
 The first subsection introduces ROS and their implications in the oxidation of 
proteins and highlights some examples of their practical applications. The next subsection 
discusses metal-based oxidants as a means to oxidize substrates selectively with strong 
C–H bonds as observed in heme and non-heme proteins as well as artificial enzyme 
systems. The last subsection introduces the goals of the research presented in section two, 
where our results in the field of oxidation of amino acids by a metal-based oxidant will be 
discussed. We have synthesized amino acid substrates and conducted kinetic and 
mechanistic investigations for their reactions with [FeIV(O)(N4Py)]2+. 
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1.1.1 Reactive Oxygen Species: Implications and Sources 
 Reactions of ROS with proteins, free amino acids and polypeptides have been 
studied for decades due to their involvement in aging1, 2, 4, 5, 14-17 Sources of ROS are 
known, such as the respiratory chain, and can accumulate in the body, which can lead to 
physiological implications.5, 6, 18-20 ROS can be generated through pro-oxidants from 
environmental pollutants or in the body from processes such as lipid peroxidation or 
arginine nitric oxide synthetase.6 Generation of ROS by metal-ion catalyzed processes 
such as Fenton or Haber-Weiss type mechanisms are known.4, 6 In the Fenton reaction 
(Scheme 1.1), Fe2+ reacts with hydrogen peroxide to form hydroxyl radical,21 whereas the 
Haber-Weiss mechanism (Scheme 1.2) involves the reaction of Fe3+ with superoxide to 
form Fe2+ and O2.22, 23 The second step of the Haber-Weiss mechanism (Scheme 1.2) is 
the Fenton reaction, therefore either pathway may generate ROS by metal-ion catalyzed 
processes.  
Scheme 1.1 The Fenton Reaction 
            Fe2+ + H2O2                  Fe
3+ + OH – + OH  
Scheme 1.2 The Haber-Weiss Reaction 
Step 1: Fe3+ + O2
 –                    Fe2+ + O2
Step 2: Fe2+ + H2O2                  Fe
3+ + OH – + OH     (Fenton Reaction)
Overall Reaction:  O2
 –  +  H2O2                         O2   +  OH
 – + OH  
Hydroxyl radical and superoxide are not the only ROS. Others include hydrogen 
peroxide (H2O2), hydroperoxyl radical (HOO•), alkoxyl radical (RO•) and singlet oxygen 
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(1O2). Nitric oxide (NO•, formed by nitric acid synthatase), is an example of Reactive 
Nitrogen Species (RNS) and is also known to oxidize biomolecules.5, 6 NO• can react 
with superoxide or carbon dioxide to form other RNS, peroxynitrite (ONOO–) and 
nitrosoperoxocarboxylate (ONOOCO2–), respectively.5 Although there are other ROS and 
RNS capable of oxidizing proteins, the following subsection will focus on examples of 
the reactivity of hydroxyl radical, a potent ROS. 
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1.1.2 Reactivity of ROS with Proteins, Peptides and Amino Acids 
The reactivity and selectivity of ROS vary by species. For example, hydroxyl 
radical is highly reactive and therefore shows little discrimination in its residue 
specificity during oxidation of proteins. However, unlike hydroxyl radical, singlet oxygen 
and hydrogen peroxide display selectivity and oxidize single amino acid residues in 
proteins.24, 25 The rates of reaction between singlet oxygen and the amino acid residues of 
Trp, Tyr, Met, Cys and His on proteins are kinetically significant compared to the rate of 
reaction with other residues. For example, the rate of reaction of singlet oxygen with the 
amino acid residue Met was found to be 1.6 x 107 dm3 sec–1 at physiological pH.24 While 
some ROS show selectivity, the following section will focus on the description of the 
more potent hydroxyl radical. 
Accumulation of oxidized amino acid residues of proteins and peptides, also 
known as oxidative stress, has been linked to aging as well as other pathological 
conditions such as arteriosclerosis and Alzheimer’s disease.5, 6, 18-20 Supporting studies 
have illustrated that cell death can occur through the oxidation of proteins by hydroxyl 
radical generated from ionizing radiation.26 Experiments conducted over the last several 
decades have established the reactivity of ROS with amino acids and proteins 1, 5, 6, 18-20, 26 
and pioneering work identified oxidation products for these reactions.1, 14, 27-31 These 
studies mainly involve generation of ROS by radiolysis (using γ-radiation)1 or metal-
catalyzed processes. 
Identification of oxidation products and determination of the mode of action for 
the reactions of ROS with proteins is of great importance. ROS can be generated in the 
body as metabolites, enter the body through environmental pollutants or be generated 
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upon exposure to X-ray, γ-ray and UV-radiation.5 In radiolysis studies, hydroxyl radical 
or a mixture of superoxide and hydroxyl radical can form.1 H-atom abstraction via 
hydroxyl radical either at the α-C–H (1) or on the amino acid side chain has been 
established (Scheme 1.3). Trapping of carbon-centered radicals by O2 (2) leads to 
fragmentation of the backbone (diamide pathway or the α-amidation pathway) of the 
amino acid or peptide via a peroxyl and alkoxyl radical. Hydroxyl radical may trap the 
carbon- or heteroatom-centered radical resulting in hydroxylation. Cross-link formation 
via side chain radical dimerization, such as with cysteine or tyrosine, is another known 
pathway.1, 5, 6 These mechanisms have also been implicated during metal-catalyzed 
oxidation processes.5 As the length and steric hindrance of the side chain of an amino 
acid increases, chemoselectivity shifts such that reaction at the side chain dominates 
rather than at the α-C–H position.14, 32, 33 For example, glycine and alanine residues are 
mainly oxidized at the α-C–H position leading to backbone cleavage and result in the 
formation of amides and keto acid products.1, 14, 34 On the other hand, side chain oxidation 
dominates amino acids such as tyrosine forming the products 3,4-dihydroxyphenylalanine 
(DOPA) and dityrosine through cross-linkages.35 The following describes the oxidation 
of amino acid residues with ROS during radiolysis or by metal-catalyzed processes. 
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Scheme 1.3 Pathways for carbonyl product formation by reaction of ROS with peptides 
through oxidative cleavage of the backbone via the diamide pathway or the α-amidation 
pathway 
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 As mentioned above, glycine and alanine oxidation by ROS is initiated by H-atom 
abstraction at the α-C–H bond that leads to backbone cleavage, but other amino acid 
residues have either solely side chain oxidation or a mixture of side chain oxidation and 
backbone cleavage. Backbone cleavage tends to proceed to a lesser extent.1, 5 For 
example, oxidation of the side chains of glutamic and aspartic acid at the γ- and β-C–H 
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positions respectively represent the dominant pathway for their reaction with ROS, 
however, backbone oxidation of N-acetyl-glutamic acid has been observed as a minor 
product.36 Competition between side chain and backbone oxidation is also prevalent in 
amino acids such as arginine, threonine, serine and lysine.1 A summary of oxidation 
products can be found in Table 1.1 for selected amino acids. Side chains of leucine and 
valine are hydroxylated to give 3-hydroxyleucine and 4- or 3-hydroxyvaline as oxidation 
products1, 32 and phenylalanine is oxidized to ortho/meta-tyrosine. The phenol side chain 
of tyrosine is oxidized to 3,4-dihydroxyphenylalanine (DOPA) and dityrosine through 
cross-linkages.5, 6, 35, 37 Other aromatics such as tryptophan are converted to various 
derivatives such as 2-, 4-, 5-, 6- and 7-hydroxytryptophan as well as other decomposition 
products that have not been identified.1, 3, 6  
Table 1.1 Examples of oxidation products for selected amino acids with ROS (OH•) 
Amino Acid Oxidation Product(s) Ref. 
Histidine 2-oxo-histidine, aspartic acid, asparagine 5, 38 
Phenylalanine 2-, 3-, and 4-hydroxyphenylalanine and 2,3- dihydroxyphenylalanine 5 
Tyrosine dityrosine and 3,4-dihydroxyphenylalanine 35 
Tryptophan formylkynurinine, 2-,4-,5-,6-, and 7-hydroxytryptophan + others 3, 5 
Cysteine sulfenic acid and disulfides 1, 27 
Methionine methionine sulfoxide/sulfone 5 
Arginine glutamic semialdehyde 29 
Lysine α–aminoadipic semialdehyde 29, 30 
Proline glutamic semialdehyde, 2-pyrrolidone + others 29, 31 
Threonine 2-amino-3-ketobutyric acid 39 
Glutamic Acid oxalic acid 5 
Although damaging to proteins and biological substrates, ROS have found 
practicalities in the field of protein structure determination. Hydroxyl radical has been 
used in protein footprinting,40, 41 a type of structural determination for mapping surface 
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residues of proteins. These hydroxyl radicals may be generated by radiolysis or by metal-
catalysts, such as FeIIEDTA.42 Hydroxyl radical footprinting with FeIIEDTA has been 
used to explore protein-protein interactions of 16S rRNA and 30S ribosomal subunit of 
Escherichia coli.43 FeII was incorporated into this subunit by complexation with 1-(p-
bromoacetamidobenzyl)-EDTA, which was attached to the ribosomal protein S4 via a 
cysteine residue, Cys-31. Hydroxyl radical generation from a single FeII atom results in 
backbone cleavage of the rRNA near the Cys-31 residue. In footprinting, the same 
reaction is carried out using an unbound protein and through gel electrophoresis, a 
“footprint” of bands is obtained that can be compared to determine where the protein-
protein interactions are located. There will be a missing band where there are protein-
protein interactions because the bound protein eliminates cleavage at the site of 
interaction.43, 44 Another area where ROS have practical applications is in site selective 
protein cleavage and inactivation. 
By anchoring EDTA to a protein affinity group, site selective cleavage reagents 
have been identified. For example, EDTA has been attached to biotin (Figure 1.1) to 
deliver redox-active metals, such as Fe3+ or Cu2+, to the biotin binding site of 
streptavidin. Hydroxyl radical formation is directed at the biotin binding site and affords 
site selective cleavage of the protein backbone.45 
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Figure 1.1 Ligand used for site selective cleavage of streptavidin 
 Photosensitizers that generate ROS inactivate proteins by delivery of ROS upon 
exposure to light. The chromophore [Ru(bipy)3]2+, which is a highly efficient generator of 
the ROS species singlet oxygen 1O2 upon exposure to light,46 was attached to GU40C, a 
highly selective protein binding peptoid (Figure 1.2). This conjugate has been used in 
chromophore-assisted light inactivation (CALI) for the disruption of tyrosine kinase 
receptor VEGFR2. This kinase receptor is important for signaling in angiogenesis. The 
peptoid-conjugate, RuGU40C, inhibits endothelial growth factor (VEGF) mediated 
autophosphorylation of VEGFR2, thereby disrupting the receptor. Lee, Lim and Kodadek 
have shown that in the presence of light, this inhibitor is transformed from a 49 µM 
inhibitor (without light) to a 59 nM inhibitor (in the presence of light). While this 
conversion is a drastic improvement, the scope of these types of reagents is limited by the 
need for exposure to light,47 which cannot penetrate deeper than 1 cm under the skin.48  
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Figure 1.2 CALI reagent constructed from [Ru(bipy)3]2+ attached to peptoid GU40C 
As can be noted from this section, ROS, such as hydroxyl radical, are not 
selective for the oxidation of amino acid residues in peptides. However, they may be 
made into a type of selective reagent by use of a protein affinity group or ligand. CALI 
reagents are selective in their affinity group as well as their ROS, however, their scope is 
limited by access to light activation. The following section will discuss another type of 
oxidant where the reactive oxygen is not a ROS, but rather an oxygen atom bound to a 
metal center. These metal-based oxidants include heme and non-heme ferryls and while 
they are known in enzymes that activate dioxygen,12 their oxidation of proteins is 
underexplored. 
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1.1.3 Metal-based Oxidants 
1.1.3.1 Heme and Non-Heme FeIV-Oxo Enzymes 
 Activation of dioxygen is known for many heme and non-heme iron enzymes. 
These enzymes catalyze a variety of transformations that are critical in biological 
processes. An example is cytochrome P450 (Cyt P450), which catalyzes the oxidation of 
organic substrates such as lipids and xenobiotics.12 Another example is taurine:α-
ketogultarate dioxygenase (TauD), which catalyzes the oxidative decarboxylation of 2-
oxoglutarate, after which, taurine is hydroxylated and the liberated product serves as a 
source of sulfur for biological processes.49 These two enzymes will be discussed in detail 
due to the wide acceptance of the involvement of FeIV-oxo intermediates.12, 13, 50-52 
 The terminal oxidase Cyt P450 is a microsomal enzyme that activates dioxygen 
and catalyzes oxygen atom transfer via a high-valent FeIVO porphyrin π-cation radical to 
organic substrates.53 This oxygen incorporation into substrates makes the Cyt P450 
family important in biological processes. This enzyme is not only involved in destroying 
the activity of certain environmental pollutants, but plays an important part in cell death 
(cellular toxicity).54, 55 Cyt P450 has a central role in the deactivation/activation of most 
carcinogens and can influence tumor development and progression in a negative or 
positive way. It can also metabolize anti-cancer drugs thereby affecting the response of 
tumors to the specific drug.55 For these reasons the mechanism of Cyt P450 has been 
studied. It is now accepted that the catalytic cycle precedes through an FeIV-oxo 
intermediate. 
 Scheme 1.4 outlines the catalytic cycle of Cyt P450 for the oxygen atom transfer 
via a high-valent FeIVO porphyrin π-cation radical.50 Once the substrate binds to the 
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enzyme, a conformational change takes place and water leaves the axial position of the 
heme (3 to 4). Single-electron reduction of FeIII gives FeII (4 to 5) followed by binding of 
dioxygen to the axial position (6) which affords a second conformational change. Single-
electron reduction of the bound O2– gives O22– (6 to 7), which is subsequently protonated 
to give a FeIII-hydroperoxo species (8). Protonation and loss of a water molecule result in 
the formation of a high-valent FeIVO porphyrin π-cation radical (9) that reacts with R-H 
to transfer the oxygen atom. Biomimetic catalysts have been developed by many groups 
to afford oxygen atom transfer and hydroxylation of various substrates as described in 
this mechanism.56-59 
 Studies of biomimetic FeIII-porphyrins have revealed that the reactivity of the 
complexes can be controlled by the axial ligand choice as well as the electronics of the 
porphyrin. These electronics can be modified by either increasing or decreasing the 
electron-density of the aryl substituents of the porphyrin ligand.50 
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Scheme 1.4 Proposed catalytic cycle for oxygen atom transfer by heme Cyt P450 to 
substrate R-H 
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Taurine: α-ketogluterate dioxygenase (TauD) is a non-heme enzyme whose active 
oxidant has been identified as a high spin ferryl species.51, 60, 61 This enzyme affords 
oxidative decarboxylation of the α-keto carboxylate substrate 2-oxoglutarate (Figure 1.3). 
The oxidation of the C-H bond of taurine occurs concomitantly with this oxidative 
cleavage. In E.coli, TauD along with 2-oxoglutarate helps provide the microbe with a 
source of sulfur, an alternative energy source, (Scheme 1.5). Sulfur is liberated from 
hydroxylated taurine is used by the microbe during sulfate starvation.13, 62-64 
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Figure 1.3 Structure of 2-oxoglutarate 
Scheme 1.5 Reaction catalyzed by TauD and 2-oxoglutarate to yield sulfonates as an 
energy source for E.coli 
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 The mechanism of the α-ketogluterate dioxygenase family of enzymes was 
proposed almost three decades ago,64 but no evidence existed for the proposed ferryl 
species until recently.61, 63 The first evidence that a ferryl species is an intermediate was 
collected using stopped-flow absorbance along with Mössbauer spectroscopy (using a 
freeze-quench technique) on TauD (15, Scheme 1.6).61 Further evidence for 15 as an 
intermediate came from the observation of a large deuterium kinetic isotope effect (KIE = 
35) for the C-1 position of taurine.51, 65 Finally, characterization data with EXAFS, X-ray 
crystallography and resonance Raman spectroscopy became avaliable.66, 67 A mechanism 
is proposed where 2 equatorial bound water molecules on the Fe2+ center are displaced to 
allow for binding of 2-oxoglutarate (10 to 11). The substrate taurine is introduced and the 
axial water molecule is lost (12) to allow for activation of O2 forming an Fe3+ center (13). 
Oxidation of 2-oxoglutartate (14) and subsequent release of CO2 affords a ferryl (15) 
which abstracts a hydrogen atom from C-1 of taurine. This leads to the formation of an 
FeIII-hydroxyl species (16) which rebounds to hydroxylate at the C-1 position of taurine. 
Hydroxylated taurine can serve as a source of sulfur in other biological processes by the 
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breaking of the S–C bond. The release of succinate is the rate-limiting step allowing the 
process to reoccur (17 to 10).63, 64 
Scheme 1.6 Mechanism of TauD and 2-oxoglutarate for oxidation of taurine 
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 As this section has highlighted, ferryl species are biologically relevant oxidants 
found in both heme and non-heme enzymes that activate dioxygen. The following section 
introduces complexes designed to mimic these types of oxidants by generating ferryl 
species for the oxidation of substrates.  
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1.1.3.2 Non-Heme FeIV-Oxo Complexes 
There has been much interest in the past 20 years to develop catalysts that mimic 
those of heme and non-heme iron active sites that activate dioxygen to effect oxidation of 
alkanes. These mimics are usually used in conjunction with oxidants such as peroxy 
acids, hydrogen peroxide, O3 and KHSO58, 68, 69 to generate metal-based oxidants that can 
cleave C-H bonds of alkanes.57 The first well-characterized non-heme high-valent ferryl 
complex was uncovered around the same time as evidence for the involvement of a ferryl 
intermediate in TauD was observed.68, 70, 71  
Wieghardt and coworkers reported the first spectroscopic evidence for a non-
heme ferryl species in which they obtained Mössbauer and EPR data that supported a 
mononuclear, low-spin (S = 1) FeIV-oxo in biomimetic studies. The ferryl from the 
complex [FeIII(cyclam-acetato)(CF3SO3)]1+ was generated using O3 in water/acetone at –80 
°C.72 Three years later, the FeIV-oxo derived from a macrocyclic ligand, TMC, was the first 
ferryl to be isolated and a crystal structure was obtained. In the reaction of 
[FeII(TMC)(OTf)2] with iodosyl benzene (PhIO) in acetonitrile at –40 °C, a pale green 
species was formed in 2 min with a yield greater than 90% (Figure 1.4). This species had a 
λmax = 820 nm with an extinction coefficient of 400 M–1cm–1. It was also observed that 
hydrogen peroxide would afford the same species, however, 3 equiv of the oxidant and 3 h 
was needed to achieve the quantity generated in 2 min with PhIO. The species was shown to 
be stable at –40 °C for approximately one month and decayed at room temperature. Mass 
spectrometry data along with X-ray diffraction data were collected. The crystal structure of 
[FeIV(O)(TMC)(NCCH3)](OTf)2 was in good agreement with EXAFS data for synthetic 
FeIV-oxo porhyrin complexes.73, 74 The Fe-O bond length was found to be 1.646(3) Å 
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which is shorter than bond lengths observed in di-oxo-bridged species that have single Fe-
O bonds.68 
N N
N N
Fe
O
NCCH3  
Figure 1.4 Structure of ferryl derived from TMC, [FeIV(O)(TMC)(NCCH3)]2+  
Ferryls have been used in a variety of transformations including catalytic 
epoxidation of olefins,75 hydroxylation reactions and oxygen atom transfer reactions.8, 76 
Studies show that the structure of the ligand has an influence on the ferryl’s stability and its 
reactivity with substrates.8, 68, 69 As was mentioned previously, the ferryl derived from the 
ligand TMC was more stable at lower temperatures and decayed upon exposure to ambient 
temperature. The ferryl derived from TPA is not thermally stable at room temperature. In 
contrast, the ferryls derived from the pentadentate ligands N4Py and Bn-TPEN (Figure 1.5) 
have been observed to be thermally stable at room temperature. In fact, the ferryl derived 
from N4Py, [FeIV(O)(N4Py)]2+, is stable for several days at room temperature (Figure 
1.6).8 The difference in denticity is most likely an important factor in the observed stability 
between TPA and N4Py or Bn-TPEN ferryls. While [FeIV(O)(N4Py)]2+ is stable for several 
days at room temperature, pH appears to play a role in stability as well; this ferryl was 
reported to be stable between pH 5-6, 69, 76, 77 however a recent report by Que and coworkers 
show this ferryl to be stable in water at neutral pH.78 Discrepancy between the two reports 
may be due to the nature of the buffer utilized. 
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Figure 1.5 Examples of ligands used in ferryl complexes 
 
Figure 1.6 Model of [FeIV(O)(N4Py)]2+  
 The ferryls derived from Bn-TPEN and N4Py oxidize strong C-H bonds, such as 
those present in cyclohexane, with a C-H bond dissociation energy of 99.3 kcal/mol 
(Scheme 1.7). These ferryls are well characterized by various spectroscopic techniques. 
While the ferryls derived from Bn-TPEN and N4Py are more stable than others at room 
temperature, they react with hydrocarbon substrates such as triphenylmethane to afford 
oxygen atom insertion products. The reaction of [FeIV(O)(N4Py)]2+ with 25 equiv of 
triphenylmethane affords an oxygen atom insertion into the activated C-H bond of 
triphenylmethane to afford triphenylmethanol in 90% yield. Upon addition of the 
triphenylmethane at room temperature, the decomposition of the ferryl was observed by 
UV-vis spectroscopy with a concomitant generation of [FeII(N4Py)]2+ in a quantitative 
yield. Most importantly, a linear relationship was observed between the log of the second 
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order rate constant vs bond dissociation energy for many substrates. These substrates 
include Ph3CH, cumene, PhEt, PhMe and cyclohexane.8   
Scheme 1.7 Oxidation of cyclohexane by pregenerated ferryl species of polypyridyl 
ligands 
OH
[FeII(L)]2+[FeIV(O)(L)]2+
oxidant
 
 As was mentioned previously, ferryls can affect a wide variety of oxidation 
reactions such as aromatic hydroxylation,79 sulfur/phosphorous oxidation,8, 76, 80 N-
dealkylation,81 oxidation of alcohols,82 hydroxylation of hydrocarbons8 and 
epoxidation.83 Scheme 1.8 illustrates the diverse versatility of non-heme ferryl species. 
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Scheme 1.8 Transformations observed by non-heme ferryls 
[FeIV(O)(TPA)]2+
[FeIV(O)(N4Py)]2+
[FeIV(O)(N4Py)]2+
[FeIV(O)(TMC)]2+
epoxidation of alkenes:
oxidation of ROH:
aromatic hydroxylation:
sulfur oxidation:
N-dealkylation:
phosphorus oxidation:
hydroxylation of alkanes:
[FeIV(O)(TMC)]2+
[FeIV(O)(N4Py)]2+
Ph3P                                                                  Ph3PO
Type of transformation Example                                                       Ref
O
[FeIV(O)(Bn-TPEN)]2+
S S
O
OH
RH                                                                 ROH
O
O
N NH
80
79
76
7
78
73, 77
7
 
  
22 
 
1.1.4 Project Goals 
 The previous discussion involved the oxidation of various organic substrates with 
ferryls; however, none of these studies involved the oxidation of proteins. We have 
chosen to investigate the oxidation of proteins with the ferryl derived from the 
pentadentate ligand N4Py, [FeIV(O)(N4Py)]2+. As described above, this ferryl has been 
well characterized. Iron was chosen as a cofactor instead of other metals such as Ru due 
to its bioavailability.84, 85 Recently, Jackson and Kodanko have shown that polypyridyl 
ligands, such as Bn-TPEN and N4Py, can strip iron from ferritin in the presence of a 
reductant and generate FeII-complexes.86 This is an important result suggesting that FeII 
complexes could be form in cells by reduction of iron from ferritin in the presence of 
ligands such as N4Py. In order to carry out this investigation, a series of goals were 
outlined. 
The first goal was to synthesize substrates that mimic amino acid residues of 
polypeptides. These substrates would then be used in the second goal, which was to 
determine the order of reactivity for the reaction of the ferryl with each substrate. The 
third and final goal was to conduct mechanistic investigations for the most reactive amino 
acid substrates. The following sections describe the efforts made to achieve the goals of 
this project. 
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1.2 Results and Discussion 
1.2.1 Synthesis of Substrates to Mimic Amino Acid Residues of Polypeptides: Ac-
AA-NHtBu 
A collaborative effort in the Kodanko Lab was made to design and synthesize 
substrates that mimic individual amino acid residues.87 We have synthesized substrates 
for all 20 naturally occurring amino acids using solution phase methodology. These 
substrates have C-terminal and N-terminal amides installed to mimic individual residues, 
specifically tert-butyl and acetyl respectively (Figure 1.7). The substrate syntheses 
described in this section include those derived from glutamine (Gln), asparagine (Asn), 
isoleucine (Ile), tyrosine (Tyr) and cysteine (Cys) (Figure 1.8).87-89 
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Figure 1.7 Substrate to mimic amino acid residues of polypeptides 
AcHN
NHtBu
O
AcHN
NHtBu
O
AcHN
NHtBu
O
AcHN
NHtBu
O
O
NH2
O NH2 OR
R = CH3
       COCH3
Ac-Asn-NHtBu Ac-Gln-NHtBu Ac-Ile-NHtBu Ac-Tyr(OR)-NHtBu  
Figure 1.8 Substrates synthesized 
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1.2.1.1 Synthesis of Ac-Gln-NHtBu 
Synthesis of the substrate derived from Gln required no protecting groups. N-acetyl-
Gln-OH (19) was prepared by treatment of NH2-Gln-OH (18) with 4 equiv of acetic 
anhydride (76%, Scheme 1.9). The free acid (19) was then coupled with tert-butylamine 
using 1 equiv of both HOBt and EDAC to produce Ac-Gln-NHtBu (20, 54%). 
Scheme 1.9 Synthesis of Ac-Gln-NHtBu 
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1.2.1.2 Synthesis of Ac-Ile-NHtBu 
Unlike the synthesis of Ac-Gln-NHtBu, the substrate derived from Ile was not 
straightforward. While amide bond formation was facile, a diasteromeric mixture of the 
substrate was obtained during several synthesis attempts (Scheme 1.10) Epimerization at 
the α-stereocenter was difficult to suppress. A literature search uncovered that acetylation 
under basic conditions affords non-epimerized N-acetyl amino acids.90 Therefore, this 
strategy was used in place of the initial acetylation conditions of acetic anhydride and 
acetic acid. Cold sodium hydroxide was added to a mixture of H2N-Ile-OH and acetic 
anhydride to maintain an alkaline pH throughout the acetylation (21 to 22). Acetylation 
lead to formation of a single diastereomer Ac-Ile-OH (22), however, condensation with 
tert-butylamine did not (23). While many different reaction conditions and coupling 
reagents were screened, all resulted in the formation of diastereomeric mixtures. 
Examples of coupling reagents screened include HBTU, EDAC/HOBt and EDAC. 
Condensation with tert-butylamine was attempted with the succinimide ester Boc-Ile-
OSu (25), however, no product was observed.91 Epimerization at the α-carbon most 
likely resulted from the formation of an oxazolone intermediate (Scheme 1.11) that is 
easily epimerized via deprotonation. This could be due to a slower condensation with the 
bulky nucleophile, tert-butylamine. While these reaction conditions failed to produce a 
single diastereomer, one condition was found to yield the product without epimerization. 
Condensation of Fmoc-Ile-OH (27) with tert-butylamine using HBTU at –20 °C 
in THF afforded the single diastereomer Fmoc-Ile-NHtBu (59%). The solvent seems to 
play an important role in the formation of a single diastereomer as solvents such as DMF 
resulted in epimerization. The N-Fmoc group was removed using 20% piperidine/CH2Cl2 
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and the resulting primary amine, H2N-Ile-NHtBu, was acetylated. Acetylation was 
carried out using acetic anhydride in the presence of triethylamine to give Ac-Ile-NHtBu 
as a single diastereomer (28, 34% over 2 steps).  
Scheme 1.10 Synthetic trials to obtain a single diastereomer of Ac-Ile-NHtBu and final 
synthesis of a single diastereomer 
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Scheme 1.11 Oxazolone formation from the activated ester of Ac-Ile-OH 
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1.2.1.3 Synthesis of Ac-Asn-NHtBu 
The synthesis of the substrate derived from Asn, Ac-Asn-NHtBu (30), proved to 
be challenging after the initial pathway failed to produce the final product. Initial 
attempts followed the synthetic route of Ac-Gln-NHtBu (20), but condensation of Ac-
Asn-OH and tert-butylamine using the coupling reagent EDAC did not yield the product 
in a significant quantity, presumably due to complications of ring formation or 
dehydration of the side chain (Scheme 1.12).92 Another route towards 30 was attempted 
using Ac-Asp(OBn)-NHtBu87 as a starting material. Ac-Asp(OBn)-NHtBu is an 
intermediate in the synthesis the substrate Ac-Asp-NHtBu, which was previously 
synthesized in the Kodanko Lab.93 Attempts to transform the benzyl ester into an amide 
using methanolic ammonia failed.94, 95 The benzyl ester never fully converted to the 
desired amide, but instead converted to a methyl ester in addition to the desired amide, 
even at higher reaction temperatures and longer reaction times. Isolation of the substrate 
from the methyl ester was unsuccessful, therefore a third and final route was attempted. 
Scheme 1.12 Potential ring formation and dehydration of Asn side chain 
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Fmoc-Asn(Trt)-OH (29, Scheme 1.13) was utilized in the successful synthesis of 
30, and, after optimization, condensation with tert-butylamine using the coupling reagent 
isobutyl chloroformate and the base TEA at low temperature furnished Fmoc-Asn(Trt)-
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NHtBu in excellent yield (96%). The base labile protecting group was removed with 
piperidine. The free amine, H2N-Asn(Trt)-NHtBu, was acetylated to give the trityl 
protected product Ac-Asn(Trt)-NHtBu (76% over 2 steps). Finally, the acid labile trityl 
group was removed using 95:5 TFA/H2O to furnish Ac-Asn-NHtBu (30, 68%). These 
deprotection conditions allowed for ease of product isolation as the triphenylmethanol 
byproduct could be removed easily by precipitation with H2O.87 
Scheme 1.13 Synthesis of Ac-Asn-NHtBu via N-Fmoc and trityl protection 
1) Et3N, IBCF, H2NtBu, THF
2 h, –18 to –20 oC, N2, 96%
2) i. Piperidine, N2
    ii. Ac2O, Et3N, CH2Cl2
       76%, 2 steps
3) 95:5 TFA/H2O, 68%
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1.2.1.4 Optimized Synthesis of Ac-Cys-NHtBu 
Previously, Ac-Cys(Trt)-NHtBu was prepared in a 19 to 26% yield by making an 
activated p-nitrophenol-ester (31, PNP-ester) at the C-terminal before subjection to tert-
butylamine for condensation (Scheme 1.14). Before condensation, the PNP-ester was 
purified by crystallization from the reaction mixture and filtered. The product was 
subsequently washed with ethyl acetate and finally subjected to tert-butylamine. 
Crystallization and isolation of the ester by filtration led to low yields because the PNP-
ester was soluble in ethyl acetate. While the solvent and reaction mixture were cooled to 
–20 °C, the product redissolved during filtration. Attempts were made to obtain a higher 
and more consistent yield in which several coupling reagents were tested. No reagent 
gave the desired product in high yield, however, a reproducible yield of 38% was 
obtained using IBCF and no further attempts were made to optimize the coupling further. 
The removal of the trityl protecting group remained the same as the original synthesis. 
Scheme 1.14 Synthesis of Ac-Cys-NHtBu 
1) IBCF, NH2tBu, THF
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1.2.1.5 Synthesis of Ac-Tyr-NHtBu Derivatives: Ac-Tyr(OAc)-NHtBu and Ac-
Tyr(OMe)-NHtBu 
Substrates derived from Tyr (34 and 35) were synthesized in order to conduct 
experiments to provide support for the mechanisms of the ferryl with Ac-Tyr-NHtBu (33) 
and Ac-Phe-NHtBu (36, vide infra). These two unnatural amino acid derivatives, one 
with an electron-withdrawing group (EWG) and one with an electron-donating group 
(EDG), Ac-Tyr(OAc)-NHtBu (34) and Ac-Tyr(OMe)-NHtBu (35), respectively, were 
readily made from the previously synthesized 33.93  
Triethylamine was added to 33, followed by addition of acetic anhydride. This 
resulted in the facile acetylation of the alcohol group to yield 34 in a quantitative yield 
(Scheme 1.15). The base K2CO3 was added to 33 followed by iodomethane and resulted 
in the methylation of the alcohol group in a quantitative yield to provide 35. 
Scheme 1.15 Synthesis of Ac-Tyr(OMe)-NHtBu and Ac-Tyr(OAc)-NHtBu 
CH3I, K2CO3
DMF, N2
AcHN
NHtBu
O
OH
Ac2O, Et3N
0 oC to rt
AcHN
NHtBu
O
OCH3
AcHN
NHtBu
O
OAc
QuantQuant
34                                                                    33                                                                    35  
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1.2.2 Kinetic & Mechanistic Studies of Ac-AA-NHtBu with [FeIV(O)(N4Py)]2+ 
After the preparation of substrates, kinetic studies were conducted using 10 mol% 
of [FeII(N4Py)(MeCN)](ClO4)2 and KHSO5 along with 10 mM substrate. Reactions were 
carried out in a 1:1 H2O:CH3CN mixture. The ferryl, [FeIV(O)(N4Py)]2+, was preformed 
using [FeII(N4Py)(MeCN)](ClO4)2 and KHSO5 for 10 min before the addition of the 
substrate. The decomposition of the ferryl species was monitored by UV-vis spectroscopy 
at 680 nm. Decomposition of [FeIV(O)(N4Py)]2+ upon treatment with Ac-Ile-NHtBu can 
be found in Figure 1.9 and time course decay of [FeIV(O)(N4Py)]2+ at 680 nm can be 
found in Graph 1.1. It should be noted that Ac-Ile-NHtBu caused the decomposition of 
the ferryl species within the same time frame of the ferryl decomposition alone and 
therefore its reactivity, from a kinetic standpoint, was considered insignificant. 
 
Figure 1.9 UV-vis spectrum over time for the decomposition of [FeIV(O)(N4Py)]2+ (1 
mM) at 680 nm upon treatment Ac-Ile-NHtBu (10 mM) with concomitant regeneration of 
the FeII species at 450 nm 
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Graph 1.1 Time course decay of [FeIV(O)(N4Py)]2+ (1 mM) at 680 nm upon treatment of 
Ac-Ile-NHtBu (10 mM) 
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The pseudo-first order rate constants for the reaction of the ferryl with substrates 
synthesized in the previous section can be found in Table 1.2. (Conditions: 
[FeIV(O)(N4Py)]2+ = 1 mM; Ac-AA-NHtBu = 10 mM) The following subsections will 
discuss the most reactive substrates derived from cysteine (32) and tyrosine (33), as well 
as experiments with the less reactive substrate derived from phenylalanine (36).88 
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Table 1.2 Pseudo-first order rate constants and krel for substrates Ac-AA-NHtBu (krel is 
with respect to the decomposition of the ferryl alone with no substrate added) 
Ac-AA-NHtBu kobs,  s ec- 1 krel 
Cys 1.7(1) 340,000 
Tyr 3.4(1)x10-1 68,000 
Gly 5.8(2)x10-5 12 
Tyr(OMe) 2.5(2)x10-5 5 
Gln 1.6(2)x10-5 3.2 
Phe 1.4(4)x10-5 2.8 
Asn 1.4(1)x10-5 2.8 
Tyr(OAc) 1.3(1)x10-5 2.6 
Ile 5.0(5)x10-6 1.0 
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1.2.2.1 Kinetics and Mechanism of [FeIV(O)(N4Py)]2+ with Ac-Cys-NHtBu 
From Table 1.2 in the previous section, it is noted that the substrate derived from 
Cys (32) caused the decay of the ferryl faster than any other substrate with a pseudo-first 
order rate constant of 1.7(1) s–1. Due to this fast rate of reaction, a bench-top UV-visible 
spectrophotometer was equipped with a stopped-flow apparatus in order to observe the 
decay of the ferryl at 680 nm. The krel shows that the 32 caused the ferryl to decay 
340,000 times faster than the ferryl decomposition alone with no substrate added. This 
decay is shown in Graph 1.2 for the reaction in 1:1 acetonitrile/water. A second-order rate 
constant of 1.9(3) x 102 M–1s–1 was obtained from the slope of the line from Graph 1.3, 
where 5 concentrations of 32 were plotted against the rate and a linear relationship was 
observed.  
Graph 1.2 Decomposition of the ferryl (1 mM) at 680 nm upon treatment with 10 equiv 
Ac-Cys-NHtBu in CH3CN/H2O 
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Graph 1.3 Second-order plot for Ac-Cys-NHtBu (5 to 25 mM) with the ferryl (1 mM) 
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In order to study the mechanism for the reaction of [FeIV(O)(N4Py)]2+ with 32, a 
kinetic isotope effect (KIE) was determined by carrying out the reaction deuterated 
solvents (Graph 1.4). A slower pseudo-first order rate constant was observed in 
deuterated solvent, 3.7(1) x 10–1s–1, and a KIE of 4.3 was calculated using the rates 
obtained from the reactions carried out in CH3CN/H2O and CD3CN/D2O. This KIE may 
suggest an electron transfer (ET) from the sulfur of the thiol functionality to the ferryl 
that is rate limiting, followed by a proton transfer (PT) to yield a thiyl radical. However, 
based on literature, an HAT mechanism cannot be ruled out on the basis of KIE alone. 
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Graph 1.4 Decomposition of the ferryl (1 mM) at 680 nm upon treatment with 10 equiv 
Ac-Cys-NHtBu in CD3CN/D2O 
0.10
0.08
0.06
0.04
0.02
0.00
A
b
s
o
rb
a
n
c
e
8642
Time (sec)  
Support for the mechanism in Scheme 1.16 was observed in the UV-vis spectral 
data in which the regeneration of the water bound FeII(N4Py) was much slower than the 
decomposition of the ferryl, suggesting there is a lag due to the formation of a long-lived 
intermediate, in this case, an [FeIII(OH)(N4Py)]2+. Further support comes from the fact 
that thiols are strong reducing agents and have a high redox potential of +0.9 mV, 
therefore, an ET to the ferryl should be facile. These observations support the proposed 
mechanism in Scheme 1.16 where the formation of a thiyl radical by ET followed by PT 
to the ferryl leads to the formation of a disulfide. This disulfide product was observed by 
ESI-MS and a yield of 61%, with respect to the ferryl, was determined by internal 
standard (cyclooctadiene) using 1H-NMR spectroscopy. Interestingly, no oxidation of 32 
was observed that lead to the addition of one or more oxygen atoms to the sulfur, such as 
sulfenic or sulfinic acid. The disulfide was the only oxidation product detected. 
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Scheme 1.16 Proposed ET-PT mechanism for the reaction of the Ac-Cys-NHtBu with 
[FeIV(O)(N4Py)]2+ 
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1.2.2.2 Kinetics and Mechanism of [FeIV(O)(N4Py)]2+ with Ac-Tyr-NHtBu  
Ac-Tyr-NHtBu (33) caused the decay of the ferryl faster than all other substrates, 
except 32, with a pseudo-first order rate constant of 3.4(1) x 10–1 s–1. A stopped-flow 
apparatus was employed as in the case of 32. Ac-Tyr-NHtBu caused the ferryl to decay 
68,000 times faster than the decomposition of the ferryl alone with no substrate added 
(Graph 1.5). As was the case with the 32, when a plot of five concentrations vs rate was 
plotted, a linear relationship was observed with the slope of the line giving a second order 
rate constant of 4.2(3) x 101 M–1 s–1 (Graph 1.6). Due to the dissolution of a polymeric 
substance, most likely a tyrosine polymer, the identity of the product was not determined.  
Graph 1.5 Decomposition of the ferryl (1 mM) at 680 nm upon treatment with 10 equiv 
Ac-Tyr-NHtBu in CH3CN/H2O 
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Graph 1.6 Second-order plot for Ac-Tyr-NHtBu (5 to 25 mM) with the ferryl (1 mM) 
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While the rate of reaction with the ferryl was only second to 32, the rate changed 
significantly upon carrying out the reaction in CD3CN/D2O, kobs = 1.2(1) x 10–2 s–1, and a 
large KIE of 29 was obtained (Graph 1.7). Large KIEs have been observed in non-heme 
enzymes that activate dioxygen, such as TauD.49, 66 Such a large KIE suggests that the 
ferryl species reacts with Ac-Tyr-NHtBu via a HAT mechanism, however, further studies 
were conducted to support this hypothesis.  
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Graph 1.7 Decomposition of the ferryl (1 mM) at 680 nm upon treatment with 10 equiv 
Ac-Tyr-NHtBu in CD3CN/D2O 
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Since a HAT mechanism was hypothesized, the result would lead to a phenoxyl 
radical which would be observable by electron paramagnetic resonance spectroscopy 
(EPR). In an attempt to observe the phenoxyl radical, the reaction was freeze quenched in 
a quartz EPR tube, using liquid nitrogen immediately upon mixing, and subjected to EPR 
analysis. Only trace radical was observed, even when the reaction solutions were cooled 
in an ice bath before mixing (Figure 1.10). Due to the propensity of the tyrosyl radical to 
polymerize (it is an unstable, short-lived radical), the reaction was carried out using a 
substrate that has a more stable phenoxyl radical, 2,4,6-tri-tert-butylphenol. This phenol 
has stabilizing properties; the radical is stabilized by the electron-donating ability of the 
tert-butyl groups and by resonance delocalization to lead to three tertiary radicals within 
the aromatic ring (Scheme 1.17, only one resonance within the ring is shown). As was 
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expected, an intense resonance indicative of an organic radical was observed at g = 
2.0045 (Figure 1.11). 
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Figure 1.10 X-band EPR spectrum of [FeIV(O)(N4Py)]2+ (1 mM) upon treatment with 
substrate Ac-Tyr-NHtBu (10 equiv) in 1:1 H2O:MeCN at 0 °C; frozen in liquid N2 after 
less than 15 seconds. Experimental Conditions: temperature, 125 K; microwaves, 10 mW 
at 9.34 GHz; modulation, 0.55 G; receiver gain, 100. 
Scheme 1.17 Stabilizing properties of 2,4,6-tri-tert-butylphenol 
OH
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Figure 1.11 X-band EPR spectrum of [FeIV(O)(N4Py)]2+ (1 mM) upon treatment with 
2,4,6-tri-tert-butyl phenol (10 equiv) in 1:1 H2O:MeCN at 0 °C; frozen in liquid N2 after 
less than 15 seconds. Experimental Conditions: temperature, 125 K; microwaves, 1.1 
mW at 9.34 GHz; modulation, 0.55 G; receiver gain, 100. 
Based on the EPR results, it is evident that the ferryl is reacting with the hydrogen 
atom of the phenol group. Additional support comes from the Tyr derivatives (34 and 
35), where the phenolic oxygen has been acetylated or methylated thereby shutting down 
the possibility of a HAT. Both these derivatives are much slower to react with the ferryl, 
26,000 and 16,000 times slower, respectively. The reactivity of these derivatives provides 
evidence that supports a mechanism in which the fast reaction of the ferryl with 33 is due 
to the presence of a hydrogen atom of the phenol functional group. 
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1.2.2.3 Kinetics and Mechanism of [FeIV(O)(N4Py)]2+ with Ac-Phe-NHtBu 
A former co-worker in the Kodanko Lab identified the product of the reaction 
between Ac-Phe-NHtBu (36) and [FeIV(O)(N4Py)]2+ as an orthoquinone (Scheme 1.18).89 
Ac-Phe-NHtBu caused the decomposition of the ferryl with a pseudo-first order rate 
constant of 1.4(4) x 10–5 s–1. This rate was not considered significant from a kinetic 
standpoint since 36 only accelerated the decay of the ferryl by a factor of 2.8. 
Nevertheless, a comparison to the mechanism of the Tyr substrate was of interest.  
Scheme 1.18 Orthoquinone product from the oxidation of Ac-Phe-NHtBu by 
[FeIV(O)(N4Py)]2+  
[FeIV(O)(N4Py)]2+
AcHN
NHtBu
O
AcHN
NHtBu
O
O
O
 
By creating a Hammet-like plot, using the rates of Ac-Tyr(OMe)-NHtBu, Ac-
Tyr(OAc)-NHtBu and Ac-Phe-NHtBu, a trend was noted. It was hypothesized that the 
reaction between the ferryl and 33 was an electrophilic aromatic substitution (EAS) 
through which two hydroxyl groups are added to the Phe ring and subsequent oxidation 
of the dihydroquinone product led to the diquinone that was observed by 1H NMR.96 If 
the mechanism was proceeding through an EAS, the substrate with the electron-donating 
group, Ac-Tyr(OMe)-NHtBu, should increase the rate of reaction compared to Ac-Phe-
NHtBu. Likewise, the substrate with an electron-withdrawing group should slow down 
the rate of reaction. While the graph cannot be considered a true Hammet plot, due to the 
EDG/EWG not being para to the reactive center, a trend can still be noted (Graph 1.8). 
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As was expected, the rate of decomposition for the substrate with an electron-donating 
group 35 was faster than 36, 2.5(2)x10–5 s–1 and 1.4(4)x10–5 s–1 respectively. Also, the 
substrate with an electron-withdrawing group 34 was 1.3(1)x10–5 s–1. A negative value 
for ρ (the slope of a line on a Hammet plot) would be obtained from this graph if it were 
a true Hammett plot where a trendline with a negative slope would be indicative of a 
positive build up on the ring. This data supports EAS mechanism for the reaction of the 
ferryl with 36. 
Graph 1.8 Hammett-like plot for the reaction of Ac-Phe-NHtBu, Ac-Tyr(OMe)-NHtBu 
and Ac-Tyr(OMe)-NHtBu with [FeIV(O)(N4Py)]2+ indicating electrophilic aromatic 
substitution 
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1.3 Conclusions and Future Directions 
We have designed and synthesized amino acid substrates that mimic individual 
residues of amino acids of polypeptides. The substrates derived from Cys, Tyr, Phe, Gln, 
Asn and Ile were reacted with the [FeIV(O)(N4Py)]2+ and their reactivity have been 
described. Ac-Cys-NHtBu and Ac-Tyr-NHtBu have been identified to cause the decay of 
the ferryl faster than any other of the 20 natural amino acid substrates and their 
mechanisms have been identified as ET-PT and HAT, respectively. Support for EAS with 
Ac-Phe-NHtBu was also observed through a Hammet-like plot. Reactive substrates can 
serve as guidelines for the testing of other metal-based oxidants to obtain the most 
reactive and selective oxidant toward the oxidation of specific amino acid residues. 
Tuning of the ligand system or changing the metal center may improve selectivity 
and reactivity. We have identified that, unlike hydroxyl radical, there is greater selectivity 
with ferryls in reactions with amino acids. The ferryl [FeIV(O)(N4Py)]2+ has shown 
reactivity that is kinetically significant with only 5 amino acid substrates and based on the 
results, a difference can clearly be distinguished between the reactivity of ROS vs metal-
based oxidants with amino acids.88 Future studies involve the alteration of the ligand 
environment and attachment of ligands to affinity groups as warheads to inactivate 
proteins. These warheads are the apo form of the catalyst (without iron) that will be 
directed to the target of interest by the affinity group. Presumably, these apo inhibitors 
can strip iron from ferritin to generate complexes that can oxidize amino acid residues 
and inactivate proteins.  
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1.4 Experimental  
General Considerations: All reagents were purchased from commercial suppliers and 
used as received unless otherwise stated. 1H and 13C NMR spectra were recorded on a 
Varian FT-NMR Mercury-300, 400 or 500 MHz Spectrometer. Mass spectra were 
recorded on a Waters ZQ2000 single quadrupole mass spectrometer using an electrospray 
ionization source. IR spectra were recorded on a Nicolet FT-IR spectrophotometer. UV-
vis spectra were recorded on a Varian Cary 50 spectrophotometer. 
[FeII(N4Py)(CH3CN)](ClO4)2 was synthesized according to the literature procedures.97 N-
Acetyl-amino acids were synthesized from commercially available amino acids using 
standard literature procedures. All reactions were performed under ambient atmosphere 
unless otherwise noted.88 
Caution: Perchlorate salts are potentially explosive and should be handled with care. 
General Procedure for Kinetic Experiments. Reactions of  [FeIV(O)(N4Py)]2+ with 
amino acid substrates were conducted under pseudo-first-order conditions at ambient 
temperature. Rate constants correspond to an average of three runs. The reactions were 
monitored using a UV-vis spectrophotometer and solutions were performed using the 
following procedure. [FeII(N4Py)(MeCN)](ClO4)2 (2 mM) in 3:1 H2O:MeCN (1.0 mL, 20 
µmol) was treated with a solution Oxone® in H2O (100 µL, 20 µmol, 1 equiv). Upon 
standing for 10 min, the solution color changed from orange-red to green. After 10 min, 
as judged by maximization of absorbance at 680 nm, the maximum generation of 
[FeIV(O)(N4Py)]2+ species was reached. This solution was treated with 10 equiv of a 
particular amino acid substrate in 1:3 H2O:MeCN (900 µL, 200 µmol, 10 equiv). The 
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reaction was monitored by UV-vis spectroscopy after mixing for less than 10 sec. The 
decomposition absorbance traces of the ferryl (λ = 680 nm) showed first-order decay and 
fit well to the single exponential equation [A = ΔA(1-ekt) + A0)] for substrates. Studies to 
determine KIE were conducted in the same manner as above except using the deuterated 
solvents CD3CN and D2O.88 
Experimental for Stopped-flow Kinetic Studies. Due to the high reactivity of N-Ac-
Cys-NHtBu and N-Ac-Tyr-NHtBu, which cause the decomposition of [FeIV(O)(N4Py)]2+ 
within a few seconds, a stopped-flow apparatus was employed. The procedure follows 
that of the general procedure for kinetic experiments, except the two solutions were 
loaded separately in syringes and were mixed using a KSHU stopped-flow apparatus. A 
Varian Cary 50 spectrophotometer was used to measure the absorbance at a single 
wavelength, 680 nm. Studies to determine KIE using stopped-flow conditions were 
conducted in the same manner as above except using the deuterated solvents CD3CN and 
D2O.88 
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Experimental procedures and characterization data for new compounds: 
AcHN
O
NHtBu
NH2O
Chemical Formula: C11H21N3O3
Molecular Weight: 243.30
 
2-Acetamido-N-tert-butylpentanediamide. Tert-butylamine (2.70 mL, 36.4 mmol) was 
added to a mixture of EDAC (3.48 g, 18.2 mmol), HOBt (2.46 g, 18.2 mmol), N-Ac-Gln-
OH (3.42 g, 18.2 mmol), and DMF (34 mL) in a dropwise fashion. After stirring at room 
temperature under an inert atmosphere for 14 h, the mixture was concentrated in vacuo. 
The resultant gummy liquid was titurated with DCM (35 mL). The solid that formed was 
filtered and washed with DCM. The white solid was dried in a vacuum desiccator over 
P2O5 with KOH to yield N-Ac-Gln-NHtBu, (2.48 g, 56%). m.p. = 204-206 °C; 1H NMR 
(DMSO-d6) δ 7.84 (d, J = 8.9 Hz, 1H), 7.48 (s, 1H), 7.26 (s, 1H), 6.72 (s, 1H), 4.17 (m, 
1H), 2.03 (m, 2H), 1.82 (s, 3H), 1.64 (m, 2H), 1.23 (s, 9H); 13C NMR (DMSO-d6) δ 
178.1, 174.2, 172.5, 53.9, 51.7, 31.3, 27.8, 27.4, 21.8; IR (KBr) 3367, 3312, 3135, 2981, 
2957, 2913, 2860, 2821, 1671, 1564, 1542, 1439, 1362, 1290 cm-1; LRMS (ESMS) calc’d 
for C11H22N3O3 (M+H)+: 244, found: 244.93 
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AcHN
O
OAc
Chemical Formula: C17H24N2O4
Molecular Weight: 320.38
NHtBu
 
4-(2-acetamido-3-(tert-butylamino)-3-oxopropyl)phenyl acetate. At 0°C under an 
inert atmosphere, acetic anhydride (350 µL, 3.59 mmol) was added to a mixture of 
triethylamine (750 µL, 5.45 mmol), N-Ac-Tyr-NHtBu (500 mg, 1.79 mmol) and DMF 
(10 mL). The reaction mixture was allowed to warm to room temperature and was stirred 
for 12 h. The reaction mixture was concentrated in vacuo and the residue was dissolved 
in ethyl acetate (10 mL), washed with NH4Cl (3 x 10 mL), NaHCO3 (3 x 10 mL) and 
brine (3 x 10 mL). The organic layer was concentrated in vacuo after drying over 
anhydrous sodium sulfate. The solid was collected by vacuum filtration after stirred with 
ether (2 mL). Product was dissolved in CH2Cl2 (3 x 10 mL) and concentrated in vacuo to 
yield N-Ac-Tyr(OAc)-NHtBu (0.55 g, quantitative). m.p. = 225-227°C; 1H NMR 
(DMSO-d6) δ 8.03 (d, J = 8.9 Hz, 1H), 7.52 (s, 1H), 7.24 (d, J = 8.0 Hz, 2H), 6.98 (d, J = 
8.1 Hz, 2H), 4.44 (m, 1H), 2.84 (dd, J = 13.8 Hz, 5.7 Hz 1H), 2.73 (dd, J = 12.4 Hz, 8.9 
Hz 1H), 2.29 (s, 3H), 1.75 (s, 3H), 1.18 (s, 9H); 13C NMR (DMSO-d6) δ 170.4, 169.2, 
168.9, 148.9, 135.4, 130.2, 121.2, 54.1, 50.1, 37.6, 28.4, 22.5, 20.9; IR (KBr) 3282, 3074, 
2967, 2917, 1765, 1643, 1555, 1508, 1451, 1366, 1216, 1196, 1166, 1018, 911 cm-1; 
LRMS (ESMS) calc’d for C17H25N2O4 (M+H)+: 321, found: 321.88  
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AcHN
NHtBu
O
OCH3
Chemical Formula: C16H24N2O3
Molecular Weight: 292.37  
2-acetamido-N-tert-butyl-3-(4-methoxyphenyl)propanamide. Iodomethane (70 µL, 
0.97 mmol) was added to a yellow mixture of K2CO3 (220 mg, 1.50 mmol), N-Ac-Tyr-
NHtBu (220 mg, 790 µmol) and DMF (40 mL); the yellow color disappeared during the 
course of the reaction of the reaction and the reaction progress was monitored by TLC. 
Upon completion, the mixture was concentrated in vacuo. The residue was dissolved in 
CHCl3 (20 mL) and NH4Cl (20 mL) and the crude product was extracted with CHCl3 (4 x 
20 mL). The combined organic layer was washed with H2O (1 x 10 mL) and concentrated 
in vacuo after drying over anhydrous sodium sulfate. The crude product was purified by 
silica gel flash column chromatography (gradient; 2-5% MeOH:CH2Cl2) to yield N-Ac-
Tyr(OCH3)-NHtBu (0.24 g, quantitative). m.p.= 225-227°C; 1H NMR (DMSO-d6) δ 7.90 
(d, J = 8.5 Hz, 1H), 7.47 (s, 1H), 7.12 (d, J = 8.24 Hz, 2H), 6.79 (d, J = 8.2 Hz, 2H), 4.39 
(m, 1H), 3.69 (s, 3H), 2.78 (dd, J = 14.0 Hz, 5.5 Hz, 1H), 2.64 (dd, J = 13.4 Hz, 9.2 Hz, 
1H), 1.74 (s, 3H), 1.19 (s, 9H); 13C NMR (DMSO-d6) δ 170.6, 168.8, 157.7, 130.2, 129.8, 
113.3, 54.9, 54.3, 50.0, 37.5, 28.4, 22.5; IR (KBr) 3268, 3082, 2965, 2826, 1637, 1559, 
1515, 1451, 1391, 1363, 1289, 1252, 1227, 1178, 1041 cm-1; LRMS (ESMS) calc’d for 
C16H25N2O3 (M+H)+: 293, found: 293.88  
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AcHN
O
NHtBu
O
NH2
Chemical Formula: C10H19N3O3
Molecular Weight: 229.28
 
2-Acetamido-N1-tert-butylsuccinamide. Isobutylchloroformate (IBCF) (1.0 mL, 7.4 
mmol) was added, dropwise over 15 min under an inert atmosphere at –20 to –18 °C, to a 
mixture of N-Fmoc-Asn(Trt)-OH (4.00 g, 6.69 mmol), triethylamine (1.0 mL, 7.4 mmol) 
and THF (80 mL). After stirring 15 min, tert-butylamine (0.60 mL, 7.4 mmol) was added 
to the mixture over 10 min. Upon completion of the reaction, as judged by TLC analysis, 
2.3 h, the reaction mixture was concentrated in vacuo. The crude product was purified by 
silica gel flash column chromatography (EtOAc:Hexane) to yield N-Fmoc-Asn(Trt)-
NHtBu (4.24 g, 96%). Under an inert atmosphere at rt, N-Fmoc-Asn(Trt)-NHtBu (1.5 g, 
2.3 mmol) was dissolved in piperidine (20 mL) and the reaction was monitored by TLC 
analysis until complete consumption of the starting material was observed. The reaction 
mixture was concentrated in vacuo and the residue was dissolved in DCM (4 mL). 
Triethylamine (1.60 mL, 11.5 mmol) and acetic anhydride (0.22 mL, 2.3 mmol) were 
added consecutively and upon complete consumption of starting material, as judged by 
TLC analysis, the reaction mixture was concentrated in vacuo. The crude product was 
purified by silica gel flash column chromatography (EtOAc:Hexane) to yield  N-Ac-
Asn(Trt)-NHtBu, (821 mg, 76% over 2 steps). N-Ac-Asn(Trt)-NHtBu (300 mg, 0.637 
mmol) was dissolved in 95:5 TFA:H2O (4 mL) and stirred for 2.5 h under an inert 
atmosphere. H2O was added (2 mL) and the precipitate was filtered. The filtrate was 
concentrated in vacuo, ether was added to the concentrate and the resulting white 
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precipitate, N-Ac-Asn-NHtBu, was collected by filtration. The product was dried in 
vacuo (98 mg, 68%). m.p. = decomposition; 1H NMR (D2O) δ 4.41 (t, J = 7.3 Hz, 2H), 
2.59 (dd, J = 15.4, 6.5 Hz, 1H), 2.51 (dd, J = 14.7, 7.3 Hz, 1H), 1.89 (s, 3H), 1.85 (s, 9H); 
13C NMR (D2O) δ 174.8, 174.2, 171.6, 51.8, 51.6, 37.2, 27.9, 21.9; IR (KBr) 3285, 2916, 
2848, 1656, 1551, 1366 cm-1; LRMS (ESMS) calc’d for C10H19N3O3Na (M+Na)+: 252, 
found: 252.93 
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AcHN
O
NHtBu
Chemical Formula: C12H24N2O2
Molecular Weight: 228.33
 
2-Acetamido-N-tert-butyl-3-methylpentanamide. HBTU (3.21 g, 8.49 mmol) was 
added to N-Fmoc-Ile-OH (3.00 g, 8.49 mmol) and were allowed to react for 15 min in 
THF (300 mL) under an inert atmosphere at –20 to –30 °C. Tert-butylamine (0.71 mL, 
9.35 mmol) was added dropwise over 10 min and the reaction mixture was stirred for 24 
h. The mixture was concentrated to 40 mL in vacuo and the white precipitate was filtered 
after the addition of EtOAc (100 mL). The filtrate was washed with a saturated aqueous 
NH4Cl (3 × 50 mL), 5% NaHCO3 (2 × 50 mL) and saturated NaCl solution (1 × 10 mL). 
The organic layer was dried over anhydrous sodium sulfate, concentrated in vacuo and 
the resulting crude product was purified by silica gel flash column chromatography 
(EtOAc:Hexane). The product was recrystallized from hot EtOAc/Hexane to yield N-
Fmoc-Ile-NHtBu (2.04 g, 59%). N-Fmoc-Ile-NHtBu (0.33 g, 0.81 mmol) was dissolved 
in 20% piperidine/DCM (16 mL) and the reaction was stirred until complete consumption 
of the starting material was observed by TLC. The reaction mixture was concentrated in 
vacuo and CH2Cl2 (6 mL) was added. Acetic anhydride was added (0.36 mL, 3.2 mmol) 
and the reaction was stirred until complete consumption of the starting material was 
observed by TLC. The reaction mixture was concentrated in vacuo and the crude product 
was purified by silica gel flash column chromatography (Acetone:CH2Cl2) and 
recrystallized from hot EtOAc/Hexane to yield, N-Ac-Ile-NHtBu, (187 mg, 34% over 2 
steps) m.p. = 202-203 °C; 1H NMR (CD3OD) δ 7.55 (s, 1H), 4.06 (d, J = 8.9, 1H), 1.97 
(s, 3H), 1.75 (m, 1H), 1.55 (m, 1H), 1.27 (s, 9H), 1.08 (m, 1H), 0.92 (m, 6H); IR (KBr) 
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3275, 3078, 2963, 2874, 1727, 1644, 1557, 1454, 1363, 1267, 1225 cm-1; 13C NMR 
(D2O) δ 171.9, 171.8, 59.7, 59.6, 38.1, 28.8, 26.0, 22.4, 15.8, 11.3; LRMS (ESMS) calc’d 
for C12H25N2O2 (M+H)+: 229, found: 229.93  
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AcHN
O
NHtBu
SH
Chemical Formula: C9H18N2O2S
Molecular Weight: 218.32
 
2-Acetamido-N-tert-butyl-3-mercaptopropanamide. Isobutylchloroformate (0.55 mL, 
4.22 mmol) was added dropwise over 5 min, under an inert atmosphere while the 
temperature was maintained between –18 and –20°C, to a mixture of triethylamine (0.60 
mL, 4.22 mmol), N-Ac-Cys(Trt)-OH (1.55 g, 3.83 mmol) and THF (100 mL). The 
reaction mixture was allowed to warm to room temperature after the dropwise addition of 
tert-butylamine (0.32 mL, 4.22 mmol), over 10 min and the mixture was stirred for 6 h. 
The mixture was concentrated in vacuo and the crude product was purified by silica gel 
flash column chromatography (EtOAc:Hexane) to yield a white solid, N-Ac-Cys(Trt)-
NHtBu, (0.640 g, 38%). 1H NMR (CDCl3) δ 7.32 (m, 15 H), 6.90 (brd, J = 6.4 Hz, 1H), 
6.88 (s, 1H), 3.93 (m, 1H), 2.68 (dd, J = 12.9, 7.3  Hz, 1H), 2.46 (dd, J = 12.9, 6.4  Hz, 
1H), 1.89 (s, 3H), 1.28 (s, 9H). 
 A mixture of N-Ac-Cys(Trt)-NHtBu (0.400 g, 0.870 mmol), TFA (2.5 mL), and 
CH2Cl2 (2.5 mL) was stirred under an inert atmosphere for 1 h. Triethylsilane (0.21 mL, 
1.30 mmol) was added and the mixture was allowed to stir at rt for 3 h. The reaction 
mixture was concentrated in vacuo and the residue was titurated with CH2Cl2/Hexane to 
yield a crude white solid that was purified by silica gel flash column chromatography 
(EtOAc:Hexane) to yield the white solid N-Ac-Cys-NHtBu (0.120 g, 63%). m.p. = 172-
174 °C; 1H NMR (CD3OD) δ 4.35 (m, 1H), 2.75 (m, 2H), 1.98 (s, 3H), 1.32 (s, 9H); 13C 
NMR (CD3OD) δ 162.1, 161.1, 48.4, 43.3, 19.8, 18.0, 13.4; IR (thin film) 3267, 3093, 
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2964, 1631, 1569, 1447, 1386, 1363, 1259, 1225; cm-1; LRMS (ESMS) calc’d for 
C9H19N2O2S (M+H)+: 219, found: 219.93 
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CHAPTER 2  
OXIDATION OF GLUTATHIONE BY METAL-BASED OXIDANTS 
2.1 Introduction 
Glutathione (GSH) is a ubiquitous tripeptide that is involved in various cellular 
functions, including cell proliferation. It is important in the detoxification of ROS such as 
hydroxyl radical and works with other antioxidants to protect cells from oxidative stress.1 
While the role of GSH with ROS is well understood, reactions with metal-based oxidants 
have received less attention.2 Therefore the reaction of GSH with metal-based oxidants is 
worth investigating, because GSH is known to detoxify ferryls such as ferryl myoglobin 
in cells.3  
The work presented in this chapter is an extension of a result observed in the 
experiments from Chapter 1. Upon mixing of Ac-Cys-NHtBu with the ferryl 
[FeIV(O)(N4Py)]2+ in 1:1 H2O/MeCN, rapid decomposition of the ferryl at λmax = 680 nm 
was observed by stopped-flow UV-vis spectroscopy and a disulfide product was 
identified.4 When the reaction was monitored, after the initial decomposition at 680 nm, a 
new green species developed that displayed a band at λmax = 658 nm. In order to identify 
the species responsible for this new absorption band, experiments were conducted with 
Ac-Cys-NHtBu, however only trace amounts of the green species were observed and its 
formation suffered from low reproducibility. We decided to choose another thiol based 
on the hypothesis that an S→Fe ligand-to-metal-charge-transfer (LMCT) was responsible 
for λmax = 658 nm, based on literature.5 Glutathione was chosen as a likely candidate to 
substitute for the cysteine derived substrate. Besides containing a thiol group, glutathione 
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was chosen because of its immense importance in biology, which will be further 
explained in the following sections. 
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2.1.1 Glutathione: Importance in Biology 
Glutathione (L-γ-glutamyl-L-cysteine-glycine, GSH) is a multifunctional 
tripeptide composed of glutamate, cysteine and glycine (Scheme 2.1). It is responsible for 
modulation of various cellular functions, including but not limited to cell proliferation, 
storage of cysteine, detoxification (as an antioxidant), maintaining cell thiol status and 
regulation of nitric oxide homeostasis.1, 6-9 It is present in all mammalian tissues in 
concentrations up to 10 mM with the highest concentrations present in the liver. 
Approximately 90% of total GSH is located in the cytosol and 10% in the mitochondria. 
While these two areas contain a higher abundance of GSH, a small percentage can be 
found in the endoplasmic reticulum.1 GSH typically exists in a 100 to 1 ratio with its 
oxidized form (GSSG), however, during oxidative stress, the ratio of GSH to GSSG can 
decrease significantly (4 to 1).10 As mentioned above, GSH is important in various 
cellular functions, several of which are described below. 
Scheme 2.1 Glutathione is composed of the amino acids glutamate, cysteine and glycine 
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GSH is considered essential for mammalian cell survival11 and is known to play 
an important role in cell proliferation and cell death, however its comprehensive role in 
nucleated cells remains unclear.12 There have been conflicting reports in the past two 
decades concerning the concentration of GSH in the nucleus and its regulation is not 
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understood.13-17 These results are most likely due to a limit of current methodologies to 
measure GSH in the nucleus because most studies involve confluent cells even though 
the nucleus dramatically changes during each phase of the cell cycle. Cells in preparation 
of cellular division have a higher GSH content in the nucleus. While it has been shown 
that GSH concentrations increase prior to proliferation, the exact mechanism for this 
increase is under debate.12 Recently, new methods have become available to determine 
redox status of the nucleus such as redox blot,18 however, there are no present methods 
for the determination of nuclear GSSG. Further developments in this field are needed to 
understand the compartmentalization of GSH and its role in cell proliferation.  
While the mechanism of GSH transport into the nucleus is unresolved, passive 
diffusion through nuclear pores from the cytosol has been invoked.19 The redox status of 
the nucleus plays an important role in various functions. Nuclear GSH protects DNA 
from ionizing- and oxidant-induced damage20 and maintains a reducing environment 
conducive to cell cycle progression, specifically gene transcription.21 GSH is also 
involved in DNA synthesis; it is a hydrogen donor in the reduction of ribonucleotides to 
produce deoxyribonucleotides. This reduction is catalyzed by the enzyme ribonucleotide 
reductase.22, 23 As was mentioned previously, exact determination of the GSH to GSSG 
ratio has not been achieved due to the changing levels during the cell cycle.10 A 
correlation between levels of GSH in the nucleus and the anti-apoptotic protein Bcl-2 has 
been realized, but is not fully understood. It is thought that Bcl-2 maintains high nuclear 
levels of GSH and in doing so evades apoptosis.17 
While the redox status of the nucleus is still under investigation, overall GSH 
maintains intracellular redox and thiol homeostasis and the mechanisms are known. For 
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example, thiol-transferase catalyzes a reversible thiol-disulfide exchange between 
oxidized proteins and GSH. The redox status (GSH to GSSG ratio) of the cell determines 
the equilibrium direction (Scheme 2.2).1, 24 In order to limit the reverse of this reaction, 
where proteins contain mixed disulfides, the GSSG concentration is generally extremely 
low. This equilibrium regulates a variety of cellular processes including, but not limited 
to, signal transduction, enzyme activity, gene expression and transport activity.1 An 
important example where signal transduction plays a key role in the fate of the cell is 
apoptosis.10  
Scheme 2.2 Thiol-transferase reaction 
GSH + Protein-SSG                                            GSSG + Protein-SH
thiol-transferase
 
Redox status (GSH to GSSG ratio) change within the cell is an important 
signaling mechanism. A shift to favor GSSG can signal the onset of apoptosis, or 
programmed cell death. GSH homeostasis is maintained by three known mechanisms, 
reduction of GSSG by glutathione reductase, de novo synthesis and uptake of GSH across 
the plasma membrane from exogenous sources.10, 25 De novo synthesis is catalyzed by 
GSH synthetase and glutamate cysteine ligase (GCL). It occurs in the cytosolic 
compartment in two steps that are ATP dependent (Figure 2.1), with the availability of 
cysteine, from the breakdown of extracellular GSH by GGT10 or the cystathionine 
pathway,26 being rate limiting. Intracellular GSH is then transported to various 
compartments of the cell: the nucleus, the endoplasmic reticulum (ER) and the 
mitochondria. This is carried out by the help of transporters such as the carriers oxo-
glutarate and dicarboxylate which are located on the inner mitochondrial membrane and 
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aid in the transit of GSH into the mitochondria. Since synthesis takes place in the 
cytoplasm and not the mitochondria, matrix homeostasis is dependant on GSH transit.27  
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Figure 2.1 Synthesis and redox cycling in GSH homeostasis 
Each of these compartments constitutes individual redox pools that are different 
from the cytoplasm. The mitochondria displays concentrations of GSH ranging from 5 to 
10 mM and this GSH pool is separated from the cytosolic pool, metabolically, with 
respect to GSH turnover, the rate of GSH synthesis and susceptibility to oxidative 
stress.16 As was mentioned previously, GSH synthesis does not take place in the 
mitochondria because it does not contain GSH synthetase or glutamate cysteine ligase. 
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Therefore homeostasis of GSH is dependent on the transport of GSH from the cytoplasm 
compartment to the mitochondrial compartment10 via previously mentioned carriers.27 
The endoplasmic reticulum usually exhibits the same concentration of GSH as the 
cytoplasm (2 to 10 mM), however its redox equilibrium differs in that oxidized 
glutathione is favored and the majority of GSH is in the form of protein mixed 
disulfides.28 In the endoplasmic reticulum, GSH maintains the catalytic function of 
oxidoreductase and reacts with ROS generated within the ER.29, 30 Changes in the redox 
state can lead to disruptions in the function of the endoplasmic reticulum, causing the 
activation of unfolding response and even trigger cell apoptosis.10, 31  
One of GSH’s most significant roles is as an antioxidant that combats oxidative 
stress from ROS. In the previous chapter (1.1.1) generation of ROS was covered, 
especially important concerning GSH are those generated by the mitochondrial electron 
transport chain (M-ETC), including hydrogen peroxide (H2O2) and superoxide (O2•–), 
which result in lipid peroxidation. The M-ETC represents the majority of oxygen 
consumption in cells, approximately 85% to 90%.32 In order to prevent damage to the 
cell, GSH reduces hydrogen peroxide with the help of GSH peroxidase resulting in the 
reversible formation of GSSG. Oxidized GSSG may be converted back to GSH by the 
action of glutathione reductase at the expense of NADPH. In the mitochondria, this redox 
cycle is of particular importance due to the fact that no catalase is present. In the 
peroxisome, however, catalase can aid in the detoxification of hydrogen peroxide.32, 33 
Severe oxidative stress in the cell can lead to the depletion of GSH by active transport of 
GSSG out of the cell in an attempt to maintain redox equilibrium.24 Not only does GSH 
detoxify ROS by antioxidant action, it also detoxifies xenobiotics and their metabolites. 
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GSH detoxifies electrophiles such as xenobiotics and their metabolites by forming 
a conjugate with these compounds that irreversibly consumes GSH. This may either 
happen with the help of the enzyme glutathione S-transferase (GSH S-transferase) or 
spontaneously (1) (Scheme 2.3).34 Once conjoined, the conjugate is typically released 
from the cell where the extracellular enzyme γ-glutamyltranspeptidase (GGT) catalyzes 
the transfer of the γ-glutamyl moiety (2), leaving the conjugated cysteinyl-glycine. A 
cysteine-conjugate is formed by cleavage of the cysteinyl-glycine bond by dipeptadase 
(3), an enzyme that cleaves dipeptides into their constituent amino acids, which then 
becomes enzymatically acetylated by N-acetylase (4) to form a mercapturic acid. 1  
Scheme 2.3 Mercapturic pathway: detoxification of electrophiles (E) by GSH 
E+!-Glu-CySH-Gly
GSH S-transferase
!-Glu-CySE-Gly
GTT
!-Glu
CySE-Gly
dipeptidase
Gly
CySE
N-acetylase
N
H
S
O
OH
O
E
mercapturic acid
(1)
(2)
(3)
(4)
 
  
74 
 
GSH is a storage and transport vehicle for the extremely reactive amino acid 
cysteine. Due to the fact that cysteine may generate ROS during its auto-oxidation to 
cystine (Scheme 2.4) in extracellular regions, it is stored in the form of GSH until it is 
needed in biological processes. When required, GSH can be broken down into its 
constituent amino acids for incorporation into proteins.34 The process by which cysteine 
is made available through the breakdown of GSH is known as the γ-glutamyl cycle. Once 
released from the cell, the γ-glutamyl moiety is transferred by GGT to produce cysteinyl-
glycine and γ-glutamyl amino acid. From there γ-glutamyl amino acid may be directed 
back into the cell where it is converted to glutamate for reincorporation into GSH.1  
Scheme 2.4 Structure of Cystine 
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 GSH has been shown to protect cells from apoptosis induced by damage from 
ferryl myoglobin. Ferryl myoglobin is known to oxidize biomolecules such as membrane 
lipids through single electron-transfer mechanisms3 and the mechanism is thought to 
involve a tyrosine residue, although the exact mechanism is not fully understood.35 In 
these studies, ferryl myoglobin generation was shown to correlate with the induction of 
apoptosis. In cells that had been depleted of GSH, this apoptosis was enhanced 
suggesting a role for cell protection by GSH when ferryl myoglobin is formed.3  
As can be noted from this section, GSH plays a vital role in the survival of 
mammalian cells. It contributes to many aspects of cell growth, function and death. The 
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following sections will discuss two important enzymes that are scavengers of ROS, 
superoxide dismutase and catalase. These two enzymes work in conjunction with GSH as 
antioxidants to prevent oxidative damage.  
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2.1.2 Superoxide Dismutase and Catalase: ROS Scavengers 
ROS are necessary for many biological processes, such as signal transduction. 
They are also involved in enzyme regulation, activating cytokine production, elimination 
of pathogens and cell growth.36 However, there exists a delicate balance between their 
generation and their destruction by scavengers such as GSH, glutathione peroxidase 
(GPX), glutaredoxin, thioredoxin, peroxiredoxins, superoxide dismutase (SOD) and 
catalase. Any disruption in this homeostasis, by either over-production of ROS or by 
reduction in the quantity of antioxidant enzymes, leads to oxidative stress.36, 37 This 
section will focus on SOD and catalase activity in preventing oxidative stress. 
The antioxidant enzyme superoxide dismutase catalyzes the dismutation of 
superoxide to dioxygen and hydrogen peroxide (Scheme 2.5). While hydrogen peroxide 
is still an ROS, it is less reactive than superoxide. Hydrogen peroxide can diffuse and be 
destroyed by catalase or glutathione peroxidase.38, 39 There are three different forms of 
superoxide dismutase, cytosolic, mitochondrial and extracellular.40 Cytosolic SOD 
(Cu/Zn-SOD) contains two identical subunits (32 kDa), each containing a copper and 
zinc metal cluster that is bridged by a His residue.40-43 Mitochondrial SOD (Mn-SOD) is 
a 96 kDa homotetramer that has one manganese per subunit which cycles between MnIII 
and MnII.44 
Scheme 2.5 Dismutation of superoxide anions by superoxide dismutase 
2 O2     +    2 H
+ H2O2    +    O2  
 The antioxidant enzyme catalase efficiently catalyzes the formation of water and 
dioxygen from two molecules of hydrogen peroxide (Scheme 2.6).40 It consists of four 
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identical subunits. Each subunit (60 kDa) has an heme porphyrin moiety that is 
responsible for the catalytic function.40 While catalase is not essential for certain types of 
cells, it plays a key role in the tolerance of cells to oxidative stress.45 As catalase is not 
available in the mitochondria, GSH and GPX are relied upon heavily for destruction of 
hydrogen peroxide. 
Scheme 2.6 Reaction catalyzed by the antioxidant enzyme catalase 
2 H2O2 2 H2O    +    O2  
 These two enzymes work together along with several other key antioxidants to 
combat ROS generated in the cell. Figure 2.2 illustrates the importance of antioxidant 
enzymes in cells.40 Electrons can leak from the endoplasmic reticulum (ER) from 
NADPH-cytochrome P450 and FADH2 oxidases or from cytochrome b5 causing 
generation of superoxide. Xanthine and NADPH oxidases can generate superoxide in the 
cytoplasm and superoxide may leak from the mitochondrial electron-transport chain (M-
ETC). These superoxide molecules may then be destroyed by SOD to form hydrogen 
peroxide. Hydrogen peroxide may be generated in the cell by the peroxisome or may be 
released from the mitochondria. The hydrogen peroxide in turn can be destroyed by 
catalase or glutathione peroxidase (GPX). In the presence of Fe2+ or Cu+, hydrogen 
peroxide may be converted to hydroxyl radical via the Fenton reaction which may in turn 
react with glutathione.40 
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Figure 2.2 Cellular ROS and the role of antioxidant enzymes 
 The enzymes SOD and catalase have been used extensively throughout the 
literature in mechanistic studies or as scavengers in experiments. We have used these two 
enzymes in mechanistic studies and will discuss these results in the next sections. 
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2.1.3 Copper-catalyzed Oxidation of Glutathione 
The mechanisms of oxidation of glutathione by metal complexes is lacking in the 
literature, however there are a few reports on oxidation by complexes and metal ions in 
the past five decades.46-51 The following section will discuss one report in particular, 
which illustrates the complex nature of the oxidation mechanisms. The authors elucidated 
the mechanism of copper-catalyzed oxidation of GSH, which was unclear in the 
literature. 
 It is known that the glutathione thiol may react with dioxygen in the cell in the 
presence of copper or iron to form ROS. While it is understood that superoxide, hydrogen 
peroxide and hydroxyl radical can form, the mechanism and stoichiometry remained 
unclear. Low valent-metal reduction of dioxygen,52 as well as oxidation by a glutathione 
anion radical53 are likely pathways that have been suggested for the generation of 
superoxide during copper-mediated GSH oxidation. GSH has been suggested to reduce 
superoxide to hydrogen peroxide52 and, as was mentioned previously, hydroxyl radical 
may be formed by the Fenton or Haber-Weiss reactions using hydrogen peroxide in the 
presence of  iron or copper.52, 54, 55 The role of GSH is vastly contradictory depending on 
the account. Reported roles of GSH range from a simple reductant for the copper redox 
cycle to formation of Cu+-GSH complexes56, 57 that have been shown to display SOD 
activity.58 
 Kachur, Koch and Biaglow have used dioxygen consumption studies and 
fluorescence and absorption spectroscopy to investigate both the involvement of ROS 
during the copper-mediated oxidation of GSH as well as the mechanism of oxidation. To 
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study the role of hydrogen peroxide and superoxide, catalase and SOD were employed, 
respectively.48 
 They have determined the oxidation of GSH by copper to be biphasic according 
to the kinetics of dioxygen consumption and hydroxyl radical production. The 1st phase 
involves dioxygen consumption according to the stoichiometry of reaction (1) (Scheme 
2.7), where 10 µM Cu2+ reacts with 0.1 mM GSH. The addition of SOD and catalase 
resulted in a 20% and 30% decrease, respectively, in the rate of dioxygen consumption 
during the 1st phase. However, while SOD did not alter the total amount of dioxygen 
consumed, catalase decreased the total amount consumed. It was concluded from these 
data that hydrogen peroxide and superoxide were produced during the oxidation reaction 
due to their effect on the rate of consumption of dioxygen.48 
Scheme 2.7 Stoichiometry for the oxidation of GSH in the 1st phase 
Reaction (1)        4 GSH     +     O2                                   2 GSSG      +    2 H2O  
 Hydroxyl radical production was monitored by the addition of coumarin-3-
carboxylic acid (3-CCA), which is converted to 7-hydroxycoumarin-3-carboxylic acid (7-
OHCCA) upon reaction with one hydroxyl radical molecule (Scheme 2.8), and a dramatic 
increase in production was observed towards the end of the 1st phase. This increase 
corresponded to an increase (2-fold) in dioxygen consumption. Minor hydroxyl radical 
production was noted before the end of the 1st phase. This sudden change suggests the 
appearance of a different mechanism, the 2nd phase of oxidation. During the 2nd phase, 
excess dioxygen is consumed when compared to the predictions from the stoichiometry 
of reaction (1).48 
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Scheme 2.8 Oxidation of 3-CCA by hydroxyl radical to yield fluorescent 7-OHCAA 
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 Ellman’s reagent (DTNB) was used to determine the [GSH]free during the 1st 
phase. By varying the copper concentration that was mixed with GSH, they were able to 
correlate the absorbance at 412 nm (corresponding to amount of free thiol) directly to the 
copper concentration. As the concentration of copper was increased, the absorbance at 
412 nm decreased. This suggested to the authors that a 1:1 Cu2+:GSH complex was being 
formed as the initial reaction between copper and GSH was slow. A Cu2+-GSH complex 
was also suggested by spectroscopic evidence, the appearance of absorption bands at 635 
nm and 810 nm upon mixing of Cu2+ and GSH.48  
 While they found the [Cu2+] to be directly associated with the rate of dioxygen 
consumption, it did not alter the overall quantity of dioxygen consumed. However, the 
production of hydroxyl radical during the 2nd phase was dependent on the [Cu2+]. At 
[Cu2+] greater than half the [GSH], a significant increase was noted in hydroxyl radical 
production. These data, unlike the data collected with DTNB, indicated that a 1:2 
Cu2+:GSH complex was at play.48 
 These data, taken together, suggest two independent and parallel pathways that 
are discussed by the authors. The formation of 1:1 and 1:2 Cu2+:GSH complexes are 
suggested and both are involved in the production of hydroxyl radical in the presence of 
hydrogen peroxide, but not superoxide. Scheme 2.9 shows the proposed mechanism, as 
  
82 
 
suggested by the authors, that supports observations when a large excess of GSH over 
Cu2+ is used, resulting in the formation of a 1:2 complex.48 Once the 1:2 complex is 
activated by electron-transfer (complex A), the reaction can follow two pathways. The 
first pathway is peroxide-dependent (1), where the generation of hydrogen peroxide leads 
to the formation of GSSG. The second pathway is superoxide-dependent (2), where 
formation of superoxide leads to the generation of GSSG. 
This discussion was meant to illustrate the complex nature of such metal-
catalyzed oxidations and the difficulties faced in elucidating the mechanism. The 
following sections will discuss my work conducted in the Kodanko lab focusing on 
elucidating the mechanism of GSH oxidation by metal-based oxidants, by both single 
turnover reactions, as well as catalytic oxidation. 
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Scheme 2.9 Copper –catalyzed mechanism for autoxidation of GSH 
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2.1.4 Project Goals 
We were interested in understanding the reaction between Ac-Cys-NHtBu and the 
ferryl species [FeIV(O)(N4Py)]2+, however due to the low reproducibility of an observed 
green intermediate, GSH was chosen as a substitute for its importance in biology. The 
first part of this project involves the characterization of an iron-GSH intermediate, 
[FeIII(SG)(N4Py)]2+, by UV-vis and EPR spectroscopy. This species was first observed 
by UV-vis spectroscopy and its formula was fit by high-resolution time-of-flight mass 
spectrometry. Kinetic and mechanistic studies were carried out for the reaction between 
the ferryl and GSH when the ferryl species was pregenerated before its reaction with 
GSH. A mechanism for the single turnover reaction has been proposed.  
Once this part of this project was completed, new literature showing the generation 
of ferryls by pentedentate iron-complexes in the presence of O2 and a reductant, inspired 
us to attempt the above experiments catalytically. This work involves the reaction of the 
complex [FeII(N4Py)(MeCN)](ClO4)2 with GSH. An initial catalyst screen was carried 
out by examining the consumption of GSH over time and key complexes were examined 
further. The reaction between GSH and the ferryl derived from N4Py was tested for 
oxygen and pH dependence. Experiments with antioxidant enzymes were conducted to 
determine whether hydrogen peroxide or superoxide were important in the rate-
determining step of the mechanism. A plausible mechanism has been suggested that fits 
with the data. 
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2.2 Results and Discussion 
2.2.1 GSH Oxidation by Ferryl [FeIV(O)(N4Py)]2+ and Characterization of the 
Intermediate [FeIII(SG)(N4Py)]2+ 
Glutathione (GSH) is involved in various cellular functions, including cell 
proliferation and apoptosis. It is important in the detoxification of ROS such as hydrogen 
peroxide and superoxide to protect cells from oxidative damage.1 Reactions of GSH with 
metal-based oxidants have not been investigated,2 therefore we have investigated the 
reaction of GSH with [FeIV(O)(N4Py)]2+ in aqueous buffer. Acetonitrile was not 
necessary as with previous experiments involving Ac-Cys-NHtBu (1.2.2.1). The reaction 
of GSH (10 mM) with [FeIV(O)(N4Py)]2+ (1 mM) leads to the formation of a green 
intermediate with λmax = 650 nm. This green species, according to literature spectral data, 
is consistent with an S→Fe ligand-to-metal-charge-transfer (LMCT).2 Due to this 
observed result, the reaction was investigated in detail and [FeIII(SG)(N4Py)]2+ 
intermediate was characterized. Kinetic analysis was carried out to determine the 
mechanism of the reaction. 
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2.2.1.1 General Reaction and UV-vis Spectroscopy for the Oxidation of GSH by 
[FeIV(O)(N4Py)]2+ 
The ferryl species [FeIV(O)(N4Py)]2+ was pregenerated in acetate buffer (100 mM, 
pH = 6.02) by treating the complex [FeII(N4Py)(MeCN)](ClO4)2 with 2 equiv of  
peracetic acid. Upon maximum generation of the ferryl species, as judged by UV-vis 
spectroscopy (680 nm), a buffer solution of GSH was added and rapid formation of a 
green intermediate with absorbance maxima at 650 nm was observed. This new band was 
distinguishable from the ferryl species, which displays λmax = 680 nm (Graph 2.1). As the 
green species at 650 nm decayed, a concurrent regeneration of [FeII(OH2)(N4Py)]2+ at 
λmax = 450 nm was noted (Graph 2.2). An 89% yield, based on extinction coefficient 
(1620 M–1 cm–1), was calculated for [FeII(OH2)(N4Py)]2+. A clear isobestic point at λmax = 
510 nm was observed, which indicated the existence of no long-lived intermediates 
during the decay of the green species (650 nm) and the regeneration of  
[FeII(OH2)(N4Py)]2+ (450 nm). Oxidized glutathione (GSSG) was observed as the 
product by electrospray ionization mass spectrometry. No other oxidation products, such 
as sulfenic or sulfonic acids, were detected. The yield of GSSG (90 ± 20%) was 
determined by monitoring the consumption of GSH using Ellman’s reagent. This yield is 
with respect to the ferryl species (single turnover oxidation) and not GSH. 
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Graph 2.1 Comparison of [FeIV(O)(N4Py)]2+ vs [FeIII(SG)(N4Py)]2+ for reaction of 1 mM 
ferryl with 5 mM GSH 
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Graph 2.2 Decay of [FeIV(O)(N4Py)]2+ (650 nm) and regeneration of 
[FeII(OH2)(N4Py)]2+ (450 nm) 
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2.2.1.2 Control Experiments 
Control experiments were run to help identity the intermediate responsible for the 
absorbance maxima at 650 nm. These experiments were meant to determine if the 
intermediate contained GSH, N4Py and iron. As was mentioned previously, the 
absorbance at 650 nm is indicative of S→Fe LMCT and control experiments with GSH 
and either FeII or FeIII perchlorate salts did not generate this absorption band. This result 
suggests N4Py is playing a role in the structure of the green intermediate. Likewise, when 
the aromatic or aliphatic thiols PhSH or EtSH were reacted with the ferryl, no absorption 
band was detected. Also, rapid formation of an absorption band at 650 nm was not 
observed when the complex [FeII(N4Py)(MeCN)](ClO4)2 was treated with GSH, 
suggesting a role for the ferryl in the formation of the green intermediate. However, when 
the aqueous solution of the complex was allowed to oxidize in air prior to reaction with 
GSH, rapid generation of the green intermediate was observed which is consistent with 
our suggested mechanism (vide infra), in which a ferric intermediate reacting with GSH 
is responsible for the formation of the green intermediate. These data taken together 
suggest GSH, iron and N4Py are involved in the structure of the green intermediate and 
that the ferryl plays an important role in its formation. The following sections will discuss 
the characterizations of the green intermediate. 
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2.2.1.3 Mass Spectrometry Data 
Mass spectrometry (MS) was used to follow the reaction of the ferryl with GSH 
and high-resolution time-of-flight (TOF)-MS was used at early time points during the 
reaction. The TOF-MS spectrum exhibited a prominent ion cluster centered at m/z 
364.5944 whose isotopic distribution fit within 5 ppm for the molecular formula of the 
dication [FeIII(SG)(N4Py)]2+ (Figure 2.3). GSH was considered to be a monoanion (GSH 
– H+) where the deprotonated thiolate is bound to the iron center. Another prominent ion 
cluster was observed at m/z 728.1821 whose isotropic distribution fit within 5 ppm for the 
molecular formula of the monocation [FeII(SG)(N4Py)]+ (Figure 2.4). For this species, 
GSH was considered to be a dianion (GSH – 2H+) due to protonation of the amine 
terminus and deprotonation of the two carboxylic acid groups (in addition to 
deprotonation of the thiol which is bound to the iron center). After allowing the reaction 
to stand for 1 h at ambient temperature, these two prominent ion clusters dissipated and a 
cluster at m/z 220.418 became the dominant ion present. The isotropic distribution fit 
within 5 ppm for the molecular formula [FeII(OH2)(N4Py)]2+. 
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Figure 2.3 High-resolution TOF-MS for [FeIII(SG)(N4Py)]2+ with m/z 364.5944 (left) 
and calculated fit (right) 
 
Figure 2.4 High-resolution TOF-MS for [FeII(SG)(N4Py)]+ with m/z 728.1829 (top) and 
calculated fit (bottom) 
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2.2.1.4 Electron paramagnetic Resonance Spectroscopy Data 
The green species was characterized by electron paramagnetic resonance (EPR) 
spectroscopy as the suspected intermediate complex, [FeIII(SG)(N4Py)]2+ is 
paramagnetic. The reaction between the ferryl and GSH was carried out and portions of 
the reaction mixture were frozen in liquid nitrogen at various time points. Spectra were 
acquired to monitor both the formation of [FeIII(SG)(N4Py)]2+, as well as its decay. 
[Experimental conditions: temperature, 120 K; microwaves, 1.0 mW at 9.34 GHz; 
modulation 2.0 G; receiver gain, 14000; GSH (5 mM) and [FeIV(O)(N4Py)]2+ (1 mM)] 
According to Graph 2.3, it can be noted that the paramagnetic species generates and 
decays within the same time frame as the peak at 650 nm, which supports both data 
corresponding to the same species. The spectrum of the intermediate, at less than 30 sec, 
displays two g-values at 2.17 and 1.98 (Graph 2.4), however, an apparent shoulder for the 
resonance at 2.17 is observed. This shoulder suggests the presence of a third unresolved 
resonance, indicating rhombic rather than axial symmetry if there were only two g-
values. Regardless of the presence of two or three resonances, the data are consistent with 
a low-spin iron(III) species as they agree with previously reported species, 
[FeIII(L)(N4Py)]2+ (L = OOH and OH).59 
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Graph 2.3 EPR spectra over time for the reaction of [FeIV(O)(N4Py)]2+ with GSH 
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Graph 2.4 X-band EPR spectra from reaction of [FeIV(O)(N4Py)]2+ (1 mM) with GSH (5 
mM) 
 
  
93 
 
2.2.1.5 Kinetic Modeling 
Variable concentration data were collected, using a stopped-flow equipped UV-
vis spectrophotometer, in order to probe the mechanism of the reaction between the ferryl 
(1 mM) and GSH (5 – 25 mM). The data were fit using Dynafit60 kinetic modeling 
software. Even though a stopped-flow apparatus was employed, the decomposition of the 
ferryl species was too fast to be observed and greater than 50% of the ferryl had 
decomposed during the deadtime of mixing. This allows for assignment of 1 x 104 M–1s–1 
as a lower limit for the rate constant (k1) of ferryl quenching by GSH. By our visual 
observations of a transient yellow color as well as on the basis of previous studies with 
Ac-Cys-NHtBu, we propose the formation of [FeIII(OH)(N4Py)]2+ as the first step of the 
mechanism for the reaction of the ferryl with GSH. Dynafit was used to determine the 
mechanism of the next two steps. Both first- and second-order processes (Scheme 2.10) 
were evaluated against various mechanistic models. Model 5 was the best fit (Graph 2.5, 
expansion in Graph 2.6) which involved a second-order reaction between 
[FeIII(OH)(N4Py)]2+ and GSH with a rate constant of 14.3(1) M–1 s–1 (k2) followed by a 
second-order decomposition of [FeIII(SG)(N4Py)]2+ (with zero kinetic order in GSH) with 
a rate constant of 1.68(1) M–1 s–1 (k3) (Scheme 2.11). The response factor that was 
optimized by Dynafit (1768 M–1cm–1, Graph 2.5) agreed well with the calculated value of 
ε650 = 1872 M–1 cm–1. 1/Abs (at λmax = 650 nm) was plotted against time and the linear 
portion of the plot was fit to y = mx + b (Graph 2.7). The extrapolated intercept is equal 
to 1/Abs (at λmax = 650 nm) for t = 0. The molar absorptivity was calculated to be 1872 
M–1 cm–1 from A = lcε; where c = 1 mM, l = 1 cm, and A = absorbance at t = 0. 
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Scheme 2.10 Theoretical models 1 – 5 considered for Dynafit 
Model 1: 
A + B ----> C : k1 ; bimolecular formation of intermediate 
C + B ----> D + E : k2 ; bimolecular decay  
Where A = [FeIV(O)(N4Py)]2+, B = GSH, C = [FeIII(SG)(N4Py)]2+, D = GSSG and  
E = [FeII(N4Py)]2+ 
 
Model 2: 
A + B ----> C : k1 ; bimolecular formation of intermediate 
C ----> D : k2 ; formation of second intermediate from first intermediate 
D + B ----> E +F : k3 ; bimolecular decomposition of second intermediate 
Where A = [FeIV(O)(N4Py)]2+, B = GSH, C = [FeIII(SG)(N4Py)]2+, D = other 
intermediate involving GSH and Fe(N4Py), E = GSSG and F = [FeII(N4Py)]2+ 
 
Model 3: 
A + B ----> C : k1 ; bimolecular formation of intermediate 
C + B ----> D + E : k2 ; bimolecular decomposition of intermediate 
C + C----> D + 2F : k3 ; bimolecular decomposition of intermediate 
Where A = [FeIV(O)(N4Py)]2+, B = GSH, C = [FeIII(SG)(N4Py)]2+, D = GSSG and  
E & F = [FeII(N4Py)]2+ 
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Model 4: 
A + B ----> C : k1 ; bimolecular formation of intermediate 
C ----> D + E : k2 ; unimolecular decomposition of intermediate 
C + E----> F + G : k3 ; bimolecular decomposition of intermediate 
Where A = [FeIV(O)(N4Py)]2+, B = GSH, C = [FeIII(SG)(N4Py)]2+, D = GS⋅,  
E & F = [FeII(N4Py)]2+ and G = GSSG 
 
Model 5: 
A + B ----> C : k1 ; bimolecular formation of intermediate 
C + C ----> D + E : k2 ; decay of intermediate 
Where A = [FeIV(O)(N4Py)]2+, B = GSH, C = [FeIII(SG)(N4Py)]2+, D = GSSG and  
E = [FeII(N4Py)]2+ 
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Graph 2.5 Best-calculated fit for kinetic model 5 for the reaction of [FeIV(O)(N4Py)]2+ 
with varying concentrations of glutathione 
 
Parameters and Standard Errors for Model 5 
Parameter Initial (mM-1min-1) Unit Fit  Unit %Error 
k1 14.2692 M-1 sec–1 14.2692 M–1 sec–1 0.5 
k2 1.6799 M-1 sec-1 1.6799 M–1 sec–1 0.7 
rC 17686.5 M-1 sec-1 17686.5 M–1 cm–1 0.1 
 
* rC : Exinction coefficient for C, [FeIII(SG)(N4Py)]2+ 
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Graph 2.6 Expansion of the first 10 minutes of absorbance vs. time for data used in the 
kinetic modeling 
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Scheme 2.11 Proposed mechanism for the reaction of [FeIV(O)(N4Py)]2+ with GSH 
[FeIV(O)(N4Py)]2+      +      GSH                          [FeIII(OH)(N4Py)]2+      +     1/2 GSSG     (k1)
[FeIII(OH)(N4Py)]2+      +     GSH                          [FeIII(SG)(N4Py)]2+      +     H2O     (k2)
2 [FeIII(SG)(N4Py)]2+      +      2 H2O                         2 [Fe
II(OH2)(N4Py)]
2+     +     GSSG    (k3)  
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Graph 2.7 Plot for molar absorptivity at 650 nm 
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 While further work is still needed to determine the structure of the green 
intermediate, two possible structures are likely based on the observed data (Figure 2.5). 
These two structures involve iron, N4Py and GSH as determined by the control 
experiments discussed earlier in this chapter. The first structure is the simple model, 
where the deprotonated thiolate is bound to the iron center. The second possible structure 
is a chelated GSH due to participation of the carboxyl group coordinating to the iron 
center. This chelated structure with a coordination number of seven may be possible due 
to the fact that coordination numbers greater than six have been observed for complexes 
of N4Py.59 
 
  
99 
 
N
N
N
Fe
NN
S
O
H
N
O
HO HN
O
NH2
O
HO
2+
N
N
N
Fe
NN
NH
NH2
OHO
O
NH
OHO
O
S
2+
 
Figure 2.5 Possible structures of [FeIII(SG)(N4Py)]2+  
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2.2.2 Catalytic Oxidation of GSH by [FeII(N4Py)(MeCN)](ClO4)2 
While the previous section covered oxidation of GSH by a pregenerated ferryl 
species, we were inspired by recent literature proving that non-heme iron-complexes 
could activate dioxygen in the presence of a reductant,61, 62 to attempt the reaction 
catalytically (Scheme 2.12). A survey of several non-heme complexes was undertaken in 
which a catalytic amount of iron complexes (1 mM) were treated with GSH (10 mM) in 
MOPS buffer (pH = 7.9). These reactions were carried out under ambient temperature 
and atmosphere using Ellman’s reagent to determine the consumption of GSH after 6 h. 
From the data collected in Table 2.1, we notice that several of the complexes display 
catalytic activity and cause rapid consumption of GSH. Importantly, complexes derived 
from Bn-TPEN, N4Py, EDTA and TPA cause faster consumption of GSH than the 
control of GSH alone or GSH with FeII(ClO4)2. These data illustrate an important ligand 
effect during the oxidation of GSH. The complex derived from TPA caused complete 
consumption of GSH in 6 h. Since these complexes were able to consume an amount of 
GSH that required catalysis, their mechanism was probed by determining the role of 
dioxygen. 
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Scheme 2.12 Possible catalytic cycle for GSH oxidation 
[FeIV(O)(N4Py)]2+  +  2 GSH [FeII(OH2)(N4Py)]
2+  + GSSG[FeII(OH2)(N4Py)]
2+
CH3CO3H
O2H2O
catalytic cycle?
 
Table 2.1 Catalyst screen for oxidation of GSH 
Catalyst [GSH] b 
control 10.0 ± 0.2 
FeII(ClO4)2 9.8 ± 0.1 
[FeII(bipy)3](ClO4)2c 10.0 ± 0.5  
FeII(TPEN)(ClO4)2c 9.2 ± 0.6 
FeII(Bn-TPEN)(OTf)2 7.4 ± 0.6 
[FeII(MeCN)(N4Py)](ClO4)2  4.3 ± 0.2 
FeIII(EDTA)(ClO4)3c 2.4 ± 0.1 
FeII(TPA)(OTf)2  0.0 ± 0.2 
 
 
a Conditions: MOPS buffer (pH = 7.9); [GSH] = 10 mM, [catalyst] = 1 mM; b [GSH] 
determined using Ellman’s reagent; data are average of three runs, errors are standard 
deviations; c iron complex formed in situ using 1 mM ligand and 1 mM Fe(ClO4)2·xH2O 
or Fe(ClO4)3·xH2O. 
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2.2.2.1 Dioxygen Consumption Studies 
 Consumption of GSH was measured, using Ellman’s reagent, during the reaction 
of [FeII(MeCN)(N4Py)](ClO4)2 (1 mM) with GSH (10 mM) under Ar (red), ambient 
atmosphere (blue, 21% O2) and under 100% O2 (black) at ambient temperature (Graph 
2.8). From the data collected, a kinetic role for O2 has been established as the reaction 
completely consumed GSH under 100% O2 but under Ar, little consumption was 
observed. While these reactions were conducted open to light, control experiments in the 
dark showed oxidation at the same rate. This is important because it excludes the need for 
light to cause homolysis of the Fe-S bond, even though oxidations through photolysis of 
FeIII-S bonds are known.63 
Graph 2.8 Consumption of GSH by [FeII(MeCN)(N4Py)](ClO4)2 under Ar (red), ambient 
O2 (blue, 21%) and 100% O2 (black) 
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2.2.2.2 Antioxidant Enzyme Inhibition Study 
 As was discussed earlier in this chapter (2.1.3), the mechanism of the oxidation of 
GSH has been shown to be complicated involving ROS-, such as superoxide and 
hydrogen, and pH-dependent pathways.48, 64 The auto-oxidation of GSH in the presence 
of dioxygen can produce hydrogen peroxide and superoxide by either the reaction of 
GSH, reaction (1), or GS–, reaction (2), with O2 (Scheme 2.13). Due to the possibility of 
oxidation taking place via one of these two reactions, the antioxidant enzymes SOD and 
catalase were used to determine if the oxidation reactions were dependent on superoxide 
and hydrogen peroxide, respectively. These control reactions were carried out with the 
non-heme complexes derived from EDTA and N4Py. While oxidation of GSH with the 
complex derived from EDTA is completely inhibited by catalase (black, Graph 2.9), 
suggesting a role of hydrogen peroxide in the oxidation of GSH, catalase has no effect for 
oxidation of GSH by [FeII(MeCN)(N4Py)](ClO4)2 (blue) compared to the reaction 
without catalase added (red). This is an important result suggesting that the ROS 
hydrogen peroxide is not contributing to the rate determining step of the oxidation of 
GSH by [FeII(N4Py)]2+. Likewise, SOD does not halt the oxidation of GSH by 
[FeII(MeCN)(N4Py)](ClO4)2, however due to the background reaction where SOD slowly 
catalyzes the oxidation of GSH in the absence of [FeII(MeCN)(N4Py)](ClO4)2, a slight 
acceleration in the rate of consumption was observed (green). Further studies showed that 
oxidation of GSH by the complex derived from TPA exhibited the same results as 
[FeII(MeCN)(N4Py)](ClO4)2. These results are important, as they suggest no role for 
superoxide or hydrogen peroxide before the rate determining steps of the oxidation of 
GSH for the case of complexes derived from N4Py and TPA. 
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Scheme 2.13 Reactions of GSH and GS– with O2 to yield hydrogen peroxide and 
superoxide 
Reaction (1):  2 GSH   +  O2                        GSSG   +   H2O2
Reaction (2):  GS–   +   O2                          GS   +   O2  
Graph 2.9 Inhibition study with SOD and catalase for the reactions of GSH with the iron 
complexes derived from EDTA and N4Py 
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2.2.2.3 pH Dependence Study and Proposed Mechanism 
 Reactions were carried out at two pH values (6.9 and 7.9) to determine if a 
dependence on pH existed. Graph 2.10 shows no pH dependence for the oxidation of 
GSH by the complex derived from TPA and slight pH dependence for the oxidation of 
GSH by the complex derived from N4Py. These data may suggest that the oxidations by 
the two complexes have similar pathways but have different mechanisms. Based on the 
data collected, lack of inhibition by SOD and catalase, a plausible mechanism has been 
suggested that involves the generation of a ferryl species (4, Scheme 2.14, the ligand 
N4Py has been omitted for clarity). The reaction of dioxygen with [FeII(N4Py)]2+ (1) 
leads to the generation of an FeIII-superoxo species 2. Reduction of 2 followed by 
protonation by GSH yields the hydroperoxo species 3. During this step, GS• dimerizes 
forming GSSG. The O-O bond of 3 homolytically fragments to form ferryl 4 
(alternatively after a single electron reduction of 3), which reacts with GSH leading to the 
formation of 5, 6 and then 1 to complete the catalytic cycle. While we have not ruled out 
other mechanisms, the conversion 1 to 3 and 4 to 1 has been demonstrated.62, 65 
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Graph 2.10 pH study for the reaction of GSH with the complexes derived from N4Py 
and TPA in the presence and absence of SOD and catalase 
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Scheme 2.14 Proposed mechanism for the catalytic oxidation of GSH 
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2.3 Conclusions and Future Directions 
In single turnover experiments with pregenerated [FeIV(O)(N4Py)]2+, we have 
observed and characterized the green intermediate [FeIII(SG)(N4Py)]2+ by UV-vis 
spectroscopy, EPR and high-resolution TOF-MS. We have also investigated the kinetics 
and proposed a plausible mechanism for the reaction of GSH with the ferryl 
[FeIV(O)(N4Py)]2+ based on the best fit model using Dynafit. Further studies are needed 
to elucidate the exact structure of the [FeIII(SG)(N4Py)]2+. 
With respect to catalytic oxidation, we have investigated several non-heme iron 
complexes in the oxidation if GSH. Results conclude that complexes derived from Bn-
TPEN, N4Py, EDTA and TPA cause consumption of GSH faster than the controls, 
however, the mechanism of the EDTA complex involves the generation of hydrogen 
peroxide as indicated by experiments with catalase. On the other hand, complexes 
derived from N4Py show no inhibition by SOD or catalase suggesting a metal-based 
oxidant being involved in the oxidation of GSH rather than of hydrogen peroxide or 
superoxide. We have shown dioxygen dependence for the oxidation of GSH with 
[FeIV(O)(N4Py)]2+ and that pH does not play a significant role in the oxidation process. 
Based on the evidence, we have suggested a plausible mechanism that involves reductive 
activation of O2. Further work is needed in this area such as further studies to elucidate 
the mechanism of the oxidation, as it is possible the ferryl species may not be generated 
during the reaction. While we have ruled out generation of hydrogen peroxide and 
superoxide as being important before the rate-determining step. Experiments will need to 
be carried out to eliminate or support the possible generation of hydroxyl radical. If the 
conversion of 3 to 4 in Scheme 2.14 involves homolytic cleavage of the O-O bond, then 
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hydroxyl radical should be produced and if scavenged, could reduce the quantity of GSH 
consumed. 
Other experiments needed include the examination of other ligands that form iron-
complexes, such as tacpyr. Further examination of the reaction of these complexes, as 
well as the complexes used in the initial catalyst screen, will needed to be looked in 
further detail. This will include earlier time point determination of GSH. The catalyst 
screen showed TPA had depleted all GSH by 6 h, however, it is not known yet if this 
depletion is completed at earlier time points, such as 1 or 2 h. Also, catalyst-loading 
studies should be preformed to determine the optimal amount of catalyst needed. 
An important practical application of the research developed here would be in the 
field of cancer. It is known that cancer cells contain a higher amount of ROS and 
therefore are more susceptible to oxidative stress by GSH depletion than normal cells.66 
Key complexes should be tested in cellulo and in vivo for anticancer activity via GSH 
depletion and the mechanism of this depletion should be studied. 
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2.4 Experimental 
2.4.1 Single Turnover Experiments 
General Experiment: 2 equiv peracetic acid (100 µL) in water was added to 
[FeII(N4Py)(MeCN)](ClO4)2 (1mL, 2 mM) in acetate buffer (pH = 6.02). After complete 
generation of [FeIV(O)(N4Py)]2+, as judged by UV-vis spectroscopy (λ = 680 nm) on a 
Varian Cary-50 UV-vis spectrophotometer, 10 equiv reduced glutathione (0.9 mL, 22.2 
mM) in acetate buffer (pH = 6.02) was added and mixed for 3 seconds before scanning 
and monitoring the intermediates generation and decay at λ = 650 nm. Upon mixing, 
analyses were conducted using specific instrumentation (see the following descriptions 
for details). All buffers were prepared using Millipore water and 
[FeII(N4Py)(MeCN)](ClO4)2 solutions were dissolved in the buffer immediately before 
use.65  
Stopped-flow Kinetics: Spectra were collected using an Applied Photophysics 
stopped-flow apparatus and a Varian Cary-50 UV-vis spectrophotometer. Sample 
experiment is as follows: [FeIV(O)(N4Py)]2+ (2 mM in a syringe) was reacted with 
glutathione (20 mM in a syringe) in acetate buffer (pH = 6.02) via pressure pump that 
mixed the syringe solutions in a 1 to 1 ratio and the reaction was monitored by UV-vis 
spectroscopy at λmax = 650 nm. Data were collected for five concentrations (5 mM, 10 
mM, 15 mM, 20 mM, and 25 mM as final concentrations) of glutathione. The absorbance 
vs. time data were cut after the residual [FeIV(O)(N4Py)]2+ decomposed (< 100 ms) and 
the minimum at 650 nm was adjusted to t = 0 for fitting.65 
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Kinetic Modeling: The kinetic modeling software Dynafit60 was used to analyze 
data collected from stopped-flow equipped UV-vis spectrophotometer. [FeIV(O)(N4Py)]2+ 
(2 mM in a syringe) was reacted with glutathione (20 mM in a syringe) in acetate buffer 
(pH = 6.02) via pressure pump that mixed the syringe solutions in a 1 to 1 ratio and the 
reaction was monitored by UV-vis spectroscopy at λmax = 650 nm. The absorbance vs. 
time traces for five concentrations (5 mM, 10 mM, 15 mM, 20 mM, and 25 mM) of 
glutathione was used for the calculations. The data were evaluated using 5 possible 
mechanistic models and rate constant values were treated as variables and fit. 65 
Mass Spectroscopy: Data were collected on a high resolution Time-of-Flight 
Micromass LCT Premier XE Spectrometer. The instrument was set up for routine 
determinations with water as the liquid carrier: a desolvation temperature of 350.0 °C, 
source temperature of 120.0 °C, sample cone voltage of 40.0 V, capillary voltage of 
3300.0 V, cone gas flow of 200.0 L/hr, and desolvation gas flow of 800.0 L/hr. Mass data 
were collected on samples of the above reaction mixture with 1 equiv glutathione; the 
reaction was carried out with water as the solvent.65 
EPR Spectroscopy: Data were acquired using a Bruker X-band EPR spectrometer 
for the reaction of [FeIV(O)(N4Py)]2+ (1.8 mM, 1 mL) with reduced glutathione (0.9 mL, 
22.2 mM) in acetate buffer (pH = 6.02). Upon mixing, reaction mixture samples were 
frozen at particular time points in liquid N2. Experimental conditions: temperature, 120 
K; microwaves, 1.0 mW at 9.34 GHz; modulation 2.0 G; receiver gain, 14000.65 
GSH Determination Using Ellman’s Reagent: Ellman’s reagent (50 µL, 10 mM in 
Tris buffer pH = 8.0) was added to 4.92 mL Tris buffer (pH = 8.0). To this, 25 µL 
aliquots of the reaction mixture of [FeIV(O)(N4Py)]2+ (1.1 mL, 1.8 mM) with 5 equiv 
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reduced glutathione (0.9 mL, 11.1 mM) in acetate buffer (pH = 6.02) was added and 
mixed well. The absorbance at 412 nm was recorded immediately after mixing on a UV-
vis spectrometer. By comparing the absorbance at 412 nm to a calibration curve 
(generated with various concentrations of glutathione), the concentration of reduced 
glutathione that was unreacted was calculated. Determinations of the quantity of 
glutathione remaining in solution were performed in triplicates.65 
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2.4.2 Catalytic Oxidation Experiments 
General Experiment for Reaction of Iron Complexes with GSH: 300 µL reactions 
were carried out in 96 well plates using the following conditions. Final [Fe complex] = 
1mM, [GSH] = 5 or 10 mM, and where applicable, [SOD/Catalase] = 1 mg/mL. At 
specific time points during the reaction, 10 µL aliquots were removed and diluted in 
wells containing 190 µL of the buffer used in the reaction (100 mM MOPS: pH = 6.9 or 
7.9). Glutathione concentrations were determined by adding 10 µL from dilution wells 
into wells containing a solution of Ellman’s reagent in Tris buffer (pH = 8.0) (300 µL). 
The absorption at 412 nm was recorded using a Tecan Infinite 200 microplate reader and 
converted into concentrations using a calibration curve. All reactions were run in 
triplicate to obtain averages and standard deviations. All buffers were prepared using 
Millipore water and all iron complex solutions were dissolved in deoxygenated buffer 
immediately prior to usage. FeIIIEDTA, FeIIBipy, and FeIITPEN were generated in situ 
from the ligand (NaEDTA, Bipy or TPEN) and the corresponding iron (II or III) 
perchlorate salt. [Fe(MeCN)(N4Py)](ClO4)2, [Fe(TPA)](OTf)2, [Fe(Bn-
TPEN)(OTf)](OTf) and TPEN were synthesized according to literature procedures.67-70 
Oxidized glutathione products were detected by mass spectroscopy on a Waters ZQ2000 
single quadrupole mass spectrometer using an electrospray ionization source. 
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 This dissertation is divided into two chapters, the first chapter includes an 
introduction to reactive oxygen species and their reactions with proteins. The introduction 
also covers metal-based oxidants, including both heme and non-heme enzymes that 
activate dioxygen as well as complexes that mimic these enzymes. The work discussed in 
chapter one concerns the synthesis of amino acid substrates that mimic amino acid 
residues. Substrates synthesized were derived from Gln, Asn, Ile, Cys and Tyr. Once 
synthesized, these substrates were reacted with [FeIV(O)(N4Py)]2+ under pseudo-first 
order conditions. The mechanisms for the reactions of the most reactive substrates were 
investigated. Electron-transfer proton-transfer and hydrogen atom transfer mechanisms 
are suggested for the substrates derived from Cys and Tyr, respectively, for their reaction 
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with [FeIV(O)(N4Py)]2+. An electrophilic aromatic substitution mechanism is suggested 
for the mechanism of the reaction of the substrate derived from Phe with 
[FeIV(O)(N4Py)]2+. 
 The second chapter focuses on the oxidation of glutathione by metal-based 
oxidants, both single turnover and catalytic reactions. The introduction discusses the 
importance of glutathione in biology and the mechanism of its oxidation by copper ions. 
The discussion sections cover two related projects. The first is the single turnover 
oxidation of glutathione by [FeIV(O)(N4Py)]2+, which includes the characterization of  the 
intermediate [FeIII(SG)(N4Py)]2+ by UV-Vis and EPR spectroscopy as well as high 
resolution time-of-flight mass spectrometry. The kinetics of the reaction were 
investigated through the use of kinetic modeling software and a mechanism was proposed 
for this oxidation. The second section is a discussion of the catalytic oxidation of 
glutathione by metal-based oxidants. Initial catalyst screens were conducted and 
[FeIITPA]2+ and [FeIIN4Py]2+ represent target complexes for further investigations. 
Antioxidant enzyme studies with catalase and superoxide dismutase show that hydrogen 
peroxide and superoxide are not involved before the rate-determining step of the 
oxidation. Also, no pH dependence was observed for the reaction of glutathione with 
[FeIITPA]2+, however, a slight pH dependence was observed for [FeIIN4Py]2+. These 
results suggest possible differences in mechanisms for the oxidation of GSH by iron 
complexes of N4Py and TPA, most likely due to denticity differences. 
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